Your browser is no longer supported. Please, upgrade your browser.
Settings
IWM  iShares Russell 2000 ETF daily Stock Chart
IWM [NYSE]
iShares Russell 2000 ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-2.87%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-3.07%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-1.47%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio4.21 Perf Half Y7.73%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year27.02%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range104.44 - 140.86 Perf YTD-0.27%
Dividend1.86 P/FCF- EPS past 5Y- ROI- 52W High-4.52% Beta-
Dividend %1.38% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low28.77% ATR1.78
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)40.44 Volatility1.65% 1.20%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.20 Prev Close134.78
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume27.96M Price134.49
Recom- SMA20-1.92% SMA50-1.67% SMA2006.22% Volume33,493,457 Change-0.22%
Mar-24-17 05:23PM  Stocks Tread Water Amid Healthcare Anxiety (SPY, DIA) at Investopedia
04:46PM  Stock Market Video Analysis Wk Ending 3/24/17
04:35PM  Market Shakes As Republicans Accept Defeat On Healthcare Bill
11:52AM  Stocks edge higher ahead of key health care vote
10:37AM  Key ADP Report Highlights: 298,000 New Jobs in February
07:37AM  Did Februarys Jobs Report Improve Confidence in the US Economy?
07:00AM  Trader's Daily Notebook: Finally, Some Action
Mar-23-17 06:05PM  February US Services PMI: Have US Business Conditions Softened?
01:58PM  Global Economy on the Mend: 4 Small-Cap ETF Plays
12:31PM  These Sectors Should Reward Shorts at Investopedia
11:47AM  Stocks bouncing back ahead of Obamacare repeal vote
09:54AM  NYSE Trading Glitch Could Pinch ETF Investors at Investopedia
Mar-22-17 05:02PM  Markets brace for health care vote
12:28PM  Small Caps: Rising Rates Not All Bad News at Investopedia
11:29AM  Airbnb defies Uber, Facebook failures and makes a move into China
10:37AM  Why Alcoa Looks Well Positioned for the Aluminum Industrys Upcycle
10:37AM  Why Analysts Expect AK Steels Profitability to Fall in 1Q17
07:00AM  Trader's Daily Notebook: Reading the Shake-Out Through the Eyes of ETFs
Mar-21-17 04:28PM  Stock Market Video Analysis 3/21/17
04:10PM  Bears Score First Real Victory of 2017
12:52PM  Charting the U.S. stock markets bearish near-term technical tilt at MarketWatch
12:28PM  This retail trader just crossed 100k in trading profits
12:14PM  Policy Worries Percolate: Bank Stocks, Small-Caps Tumble at The Wall Street Journal
10:39AM  Traders Are Aggressively Fading the Open
10:38AM  The Good and Bad News for U.S. Steel Corporation
09:43AM  NYSE Trading Outage Impacts $150B Worth Of ETFs
09:07AM  Gross on Cost of Credit: The Role of Control
07:37AM  Gross on Trump: Does Growth of 3%4% Seem Steep?
07:00AM  Trader's Daily Notebook: These Are Desperate Times
12:14AM  [$$] NYSE Arca Suffers Glitch During Closing Auction at The Wall Street Journal
Mar-20-17 05:54PM  [$$] NYSE Arca Suffers Glitch During Closing Auction at The Wall Street Journal
12:46PM  Stocks of smaller companies are signaling a warning for all US markets
11:53AM  Oil under pressure, as Nasdaq edges up to new all-time high
07:00AM  Transports and Small Caps Have Declining Momentum, Diamonds, Spiders, QQQ's Still Overbought
Mar-18-17 12:56PM  Hedge Fund Hairball at Forbes
08:01AM  What to expect from the stock market this week
Mar-17-17 01:29PM  Stocks Mixed As Fed Remains Somewhat Dovish (SPY, DIA) at Investopedia
11:49AM  Financial stocks sink, as G-20 leaders meet
Mar-16-17 01:50PM  Lagging small-cap stocks are not the market warning sign you might think at MarketWatch
12:35PM  US Dollar Index Fell despite the Feds Interest Rate Hike
11:48AM  Trump slashes budget, targets lower emission standards
10:43AM  Does the Feds Rate Hike Indicate a Stronger Economy?
Mar-15-17 04:37PM  Small-Cap ETFs And Gold Make Bullish Moves As Fed Rate Hike Arrives
04:36PM  Stock Market Video Analysis
11:46AM  Stocks edging higher ahead of Federal Reserve announcement
07:37AM  David Tepper: US Business Environment Might Not See a Downside
07:00AM  Trader's Daily Notebook: Would Somebody Please Change the Channel?
Mar-14-17 11:45AM  Stocks & oil slip, as winter storm Stella pounds the Northeast
09:57AM  Why David Tepper Doesnt Think the Market Is Cheap
Mar-13-17 03:34PM  Why the S&P 500 bulls should sweat the small stuff right now at MarketWatch
11:52AM  Stocks treading water, awaiting blizzard, Fed
07:00AM  Trader's Daily Notebook: Bulls Have Reason to Worry About Small-Caps
07:00AM  Extreme Momentum Readings for Stocks, but Transports and Small Caps Downgraded
Mar-12-17 05:00PM  Art Cashin warns that theres something disturbing happening in the market at CNBC
Mar-11-17 01:38PM  Market Breath Favors One Stock Scenario at Forbes
08:00AM  What to expect from the stock market this week
Mar-10-17 04:56PM  Stocks Dismiss Jobs Data as Rate Hike Looms at Investopedia
04:54PM  Stock Market Video Analysis
12:08PM  3 Best ETFs For U.S. Stocks With Positive Momentum, High Dividends
11:57AM  Small-Cap ETFs Wobble After Jobs Data But Woes For Oil ETF Grow
11:52AM  Stocks edging higher after hot jobs report, as oil sinks again
Mar-09-17 05:04PM  Biggest risk to the rally?
02:39PM  Trump is already creating jobs: trader
10:18AM  Investors Love This Small-Cap ETF
Mar-08-17 10:36AM  Did US Consumer Confidence Improve in February?
10:06AM  What S&P 500 Index Moving Averages Could Indicate
09:06AM  Why Did Canadas Manufacturing PMI Improve in February?
07:38AM  Be cautious about stocks for these 3 reasons at MarketWatch
07:36AM  US GDP in 4Q16: Is Economy at a Turning Point?
07:00AM  Trader's Daily Notebook: The Line in the Sand
Mar-07-17 02:36PM  Markets Are Asking The Real Donald Trump To Stand Up at Forbes
01:31PM  S&P 500 challenges the breakout point amid (still) bullish longer-term backdrop at MarketWatch
10:36AM  Which Economic Indicators Should Investors Watch This Week?
09:07AM  Indias Manufacturing PMI Improved after Demonetization
08:45AM  Momentum and the Markets
Mar-06-17 07:13PM  5 ways to trade today's market at CNBC
05:00PM  5 ways to trade today's market
10:36AM  Jets ETF Tanks Amid Trump Travel Ban; Gold Miners Continue To Crumble
07:00AM  Extreme Momentum Readings for Equity Averages, but Negative Divergence on Transports
Mar-04-17 10:58AM  How To Keep Riding This Bull Market at Forbes
08:01AM  What to expect from the stock market this week
Mar-03-17 05:09PM  Stocks Move Higher, but Technicals are Bearish at Investopedia
04:29PM  Stock Market Video Analysis 3/3/17
04:05PM  What to Expect from the S&P 500 Index in March 2017
Mar-02-17 03:27PM  Why Trump's Tax Plan Should Boost the Russell 2000
07:35AM  Why Flotek Industries Short Interest Is Falling
Mar-01-17 01:22PM  Feb. ETF Inflows Push 2017's Record Start To $88B
07:37AM  Buffett: Productivity and Innovation Could Drive Economic Growth
07:36AM  Flotek Industries Historical Valuation: What You Need to Know
07:00AM  Trader's Daily Notebook: Not Enough Volatility to Be Bullish
Feb-28-17 06:30PM  Brains Prefer Stories to Make Decisions
04:31PM  It Wasn't a Good Change, but at Least It Was a Change
01:09PM  Dow sustains 30-year technical breakout, vies for historic record-setting streak at MarketWatch
12:54PM  February ETF Asset Report: EM Gains, U.S. Loses
Feb-27-17 01:05PM  US Consumer Sentiment Index Slowed
12:35PM  5 Reasons Why Small-Cap ETFs Are Lagging Large Caps in 2017
09:33AM  Synthetic Shorting With ETFs at Barrons.com
09:08AM  Why Jack Bogle Believes Indexing Is a Good Investment Strategy
07:38AM  Jack Bogle Advises Investors to Focus on Long-Term Investments
Feb-25-17 11:08AM  Markets To Watch In The Week Ahead at Forbes
The investment seeks to track the investment results of the Russell 2000 Index, which measures the performance of the small-capitalization sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.
DHR Danaher Corporation daily Stock Chart
DHR [NYSE]
Danaher Corporation
IndexS&P 500 P/E27.98 EPS (ttm)3.07 Insider Own1.40% Shs Outstand693.28M Perf Week-0.76%
Market Cap59.63B Forward P/E20.06 EPS next Y4.29 Insider Trans-4.46% Shs Float608.82M Perf Month1.03%
Income2.15B PEG2.95 EPS next Q0.84 Inst Own78.30% Short Float1.01% Perf Quarter9.94%
Sales16.88B P/S3.53 EPS this Y24.80% Inst Trans0.30% Short Ratio2.68 Perf Half Y11.09%
Book/sh33.19 P/B2.59 EPS next Y8.67% ROA5.50% Target Price91.44 Perf Year20.27%
Cash/sh1.39 P/C61.88 EPS next 5Y9.48% ROE10.70% 52W Range69.75 - 88.01 Perf YTD10.50%
Dividend0.56 P/FCF23.55 EPS past 5Y2.10% ROI6.00% 52W High-2.27% Beta1.01
Dividend %0.65% Quick Ratio0.70 Sales past 5Y1.00% Gross Margin55.30% 52W Low23.31% ATR0.89
Employees62000 Current Ratio1.00 Sales Q/Q6.00% Oper. Margin15.20% RSI (14)52.70 Volatility1.02% 0.97%
OptionableYes Debt/Eq0.53 EPS Q/Q42.10% Profit Margin15.10% Rel Volume1.35 Prev Close86.30
ShortableYes LT Debt/Eq0.42 EarningsJan 31 BMO Payout15.70% Avg Volume2.30M Price86.01
Recom1.60 SMA20-0.72% SMA502.14% SMA2007.58% Volume3,112,519 Change-0.34%
Feb-24-17Upgrade Citigroup Neutral → Buy
Feb-01-17Initiated Credit Suisse Outperform $93
Jan-18-17Initiated Deutsche Bank Buy $88
Dec-13-16Resumed Morgan Stanley Overweight
Jul-11-16Reiterated Barclays Overweight $105 → $86
Jul-05-16Initiated Goldman Neutral
Jun-24-16Upgrade Bernstein Mkt Perform → Outperform
May-27-16Reiterated RBC Capital Mkts Sector Perform $96 → $99
Apr-22-16Reiterated Stifel Buy $109 → $110
Apr-22-16Reiterated RBC Capital Mkts Sector Perform $87 → $96
Apr-22-16Reiterated Barclays Overweight $104 → $105
Apr-18-16Reiterated Barclays Overweight $99 → $104
Apr-04-16Downgrade Bernstein Outperform → Mkt Perform
Jan-27-16Reiterated RBC Capital Mkts Sector Perform $93 → $87
Dec-08-15Downgrade Goldman Buy → Neutral
Oct-26-15Reiterated Argus Buy $98 → $104
Oct-23-15Reiterated Stifel Buy $98 → $103
Oct-23-15Reiterated RBC Capital Mkts Sector Perform $91 → $92
Oct-23-15Reiterated Barclays Overweight $89 → $94
Oct-01-15Reiterated Stifel Buy $100 → $98
Mar-21-17 03:20PM  Heres where these D.C.-area billionaires rank on Forbes 2017 list at bizjournals.com
Mar-20-17 04:15PM  Danaher Schedules First Quarter 2017 Earnings Conference Call PR Newswire
Mar-16-17 05:00PM  How to trade deregulation: 6 stocks
11:00AM  Danaher Corp. :DHR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017
Mar-10-17 02:30PM  Danaher Corp. :DHR-US: Earnings Analysis: 2016 By the Numbers : March 10, 2017
Mar-09-17 09:51AM  Better Buy: Danaher Corporation vs. Fortive Corp at Motley Fool
Mar-07-17 12:47PM  5 Companies Hit 52-Week Highs
Mar-06-17 06:14AM  Danaher Corp to buy Israel's AVT for $100 million
Feb-25-17 01:04PM  DANAHER CORP /DE/ Financials
Feb-24-17 12:45PM  Danaher Corp. : DHR-US: Dividend Analysis : December 30th, 2016 (record date) : By the numbers : February 24, 2017
07:35AM  Danaher upgraded by Citigroup
Feb-22-17 06:06AM  DANAHER CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
06:03AM  DANAHER CORP /DE/ Files SEC form 10-K, Annual Report
Feb-21-17 04:15PM  Danaher Announces Quarterly Dividend PR Newswire
04:15PM  Danaher Announces Appointment of Raymond C. Stevens, Ph.D. to Danaher Board PR Newswire
Feb-16-17 04:15PM  Danaher To Present At Barclays Industrial Select Conference PR Newswire
Feb-09-17 08:15AM  Post Earnings Coverage as Honeywell's Adjusted EPS Surged 14%; Reaffirms FY17 Outlook Accesswire
Feb-08-17 06:01AM  ATS Automation appoints new Chief Executive Officer CNW Group
06:00AM  ATS Reports Third Quarter Fiscal 2017 Results CNW Group
Feb-06-17 01:30PM  Locust Wood Boosts Exposure to These Companies at Insider Monkey
Feb-03-17 09:07AM  What to Expect from Danahers Future Earnings
07:37AM  A Closer Look at Danahers Leverage and Liquidity
Feb-02-17 02:35PM  Pulling Back the Curtain on Danahers 4Q16 Operating Performance
01:05PM  How Did Danahers Operating Segments Fare in 4Q16?
11:34AM  Why Danaher Stock Rose after Its 4Q16 Results
Jan-31-17 03:33PM  One of the Hottest Stocks This Year Is Still a Screaming Buy
03:09PM  Edited Transcript of DHR earnings conference call or presentation 31-Jan-17 12:30pm GMT
10:13AM  Danaher (DHR) Q4 Earnings & Revenues Top, Increase Y/Y
07:27AM  Danaher (DHR) Beats on Q4 Earnings & Revenue Estimates
07:14AM  Market Recon: Political Risk Shows Signs of Becoming Ongoing Condition
07:07AM  Q4 2016 Danaher Corp Earnings Release - 06:00 am ET
06:22AM  Danaher tops Street 4Q forecasts
06:00AM  Danaher Reports Fourth Quarter And Full Year 2016 Results PR Newswire
Jan-27-17 09:32AM  Danaher (DHR) Q4 Earnings: What's in Store for the Stock?
Jan-20-17 12:12PM  This Hedge Fund Bought $3 Billion of ABB Ltd Stock: Should You Buy, Too? at Motley Fool
Jan-18-17 09:08AM  What Investors Should Know about Danahers Leverage and Liquidity
07:37AM  A Look at Danahers 4Q16 Margin Estimates
Jan-17-17 06:56PM  Two settle U.S. charges on failing to file stock buys with regulator Reuters
04:36PM  Behind Danahers 4Q16 Revenue Estimates
03:06PM  How Do Analysts Rate Danaher ahead of Its 4Q16 Results?
01:23PM  What Factors Could Drive Danaher Stock in 2017?
Jan-11-17 04:15PM  Danaher Schedules Fourth Quarter 2016 Earnings Conference Call PR Newswire
Jan-10-17 08:02AM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
Jan-04-17 04:15PM  Danaher To Present At J.P. Morgan Healthcare Conference PR Newswire
Jan-03-17 09:09AM  Danaher May Not Have Much More Growth in Store
09:07AM  Here's Why You Avoid Fortive Now
Dec-30-16 09:30AM  The Zacks Analyst Blog Highlights: Wells Fargo, Danaher, Colgate-Palmolive, STERIS and Aetna
Dec-27-16 01:22PM  Is Danaher Corporation Stock a Buy for 2017? at Motley Fool
Dec-26-16 07:37AM  Danaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : December 26, 2016
Dec-15-16 11:37AM  Danaher Corp. Value Analysis (NYSE:DHR) : December 15, 2016
11:03AM  Danaher Does It at Barrons.com
06:00AM  Danaher Initiates 2017 Outlook PR Newswire
Dec-14-16 07:27AM  Danaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : December 14, 2016
Dec-13-16 03:05PM  4 Industrial Stock Winners From Trump's Lower Taxes at Barrons.com
Dec-09-16 05:03PM  Ecolab Declares a Dividend of $0.37 per Share
Dec-08-16 08:39AM  Pantone hopes its color of the year will improve our gloomy mood
07:53AM  Will Danaher (DHR) Gain from Restructuring Initiatives?
Dec-06-16 04:55PM  DANAHER CORP /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Stat
04:15PM  Danaher Announces Quarterly Dividend PR Newswire
Dec-02-16 10:42AM  ETFs with exposure to Danaher Corp. : December 2, 2016
Dec-01-16 08:00AM  Danaher announces leadership appointment PR Newswire
07:38AM  Danaher Corp. breached its 50 day moving average in a Bearish Manner : DHR-US : December 1, 2016
07:32AM  GE Completes Strategic Divestiture of Interbanca Business
Nov-30-16 08:43AM  GE Poised on Strategic Organic Growth with Healthcare Focus
Nov-29-16 08:09AM  3M Company Trails Industry Performance Post 3Q Earnings
08:07AM  What Does Wall Street Expect from Donaldsons Fiscal 1Q17 Earnings?
07:38AM  Crane Fundamentally Strong, '16 View Solid: Time to Buy?
Nov-28-16 05:59PM  Final Trade: P, GDX & more
05:45PM  Is U.S. Bancorp (USB) a Good Stock To Buy? at Insider Monkey
04:41PM  GE to Strategically Expand Healthcare Portfolio at RSNA 2016
08:16AM  United Technologies Shows Promise with in Line Performance
Nov-27-16 09:02PM  Here is What Hedge Funds Think About Danaher Corporation (DHR) at Insider Monkey
Nov-24-16 08:31AM  Crane Hits New 52-Week High on Solid Performance & View
Nov-23-16 06:33AM  Compass Diversified Partially Divests Fox Factory Shares
Nov-22-16 04:58PM  Snap-on: Ratcheting Up Margins and Other Vital Metrics
09:30AM  The Zacks Analyst Blog Highlights: Coca-Cola, Disney, Danaher, Halliburton and Time Warner
07:52AM  GE Collaborates with Prysm to Enhance Digital Platform
Nov-21-16 12:44PM  Top Research Reports for 21st November, 2016
11:12AM  3M: Not Much To Gain From A Trump World at Barrons.com
07:28AM  Ingersoll (IR) Poised for Top-Line Growth, Risks Remain
Nov-17-16 11:09AM  A Closer Look At Tiger Legatus Capitals Top Moves: AMAYA (AYA), Danaher Corporation (DHR) & Others at Insider Monkey
Nov-16-16 10:21AM  Joel Greenblatt's Top 3 New Holdings for the 3rd Quarter
10:10AM  Merrill Lynch Makes 2 Huge New Additions to US 1 Stock List at 24/7 Wall St.
08:12AM  GE Solidifies Presence in Molecular Imaging with DILON Deal
Nov-15-16 06:03PM  [$$] Gap Names Former Kraft Finance Chief as Next CFO at The Wall Street Journal
09:14AM  United Technologies' Arm in Deal with Mexican VivaAerobus
07:34AM  GE Digital Buys ServiceMax to Augment Industrial Internet
Nov-14-16 04:15PM  Danaher To Webcast Investor And Analyst Meeting PR Newswire
11:52AM  3M & Danaher: Do Earnings Even Matter in Trump's Brave New World? at Barrons.com
Nov-10-16 07:37AM  DANAHER CORP /DE/ Files SEC form 8-K, Other Events
Nov-04-16 07:20PM  Danaher Completes Acquisition Of Cepheid PR Newswire
Nov-03-16 07:18AM  UTX's Pratt & Whitney Consortium to Power A320ceo Aircraft
Nov-01-16 08:15AM  Danaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : November 1, 2016
Oct-31-16 04:15PM  Danaher to Present at Baird Industrial Conference PR Newswire
Oct-28-16 08:15AM  Post Earnings Coverage as Danaher Q3 Earnings Shine on Acquisition Accesswire
Oct-25-16 04:13PM  DANAHER CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obli
02:42PM  ETFs with exposure to Danaher Corp. : October 25, 2016
11:05AM  Danaher Marginally Raises Its Fiscal 2016 Guidance on Better YTD Performance
10:56AM  3M (MMM) Marginally Beats Q3 Earnings, Trims 2016 Guidance
10:05AM  With Phenomenex, Danaher Has an Attractive Consumables Asset
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, and surgical and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The company offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. The company's products comprise implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, consumables, software, and services for various printing, marking, coding, traceability, packaging, design, and color management applications on consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ellis Brian WSenior Vice President - GCFeb 28Sale86.0098384,5336,174Mar 01 04:31 PM
Lalor Angela SSVP, Human ResourcesFeb 27Sale86.206,044521,01754,106Mar 01 04:35 PM
COMAS DANIEL LEVP & CFOFeb 27Sale86.0910,250882,443157,765Mar 01 04:28 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerFeb 24Option Exercise19.8937,870753,23464,082Feb 27 06:22 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerFeb 24Sale85.6037,8703,241,59626,212Feb 27 06:22 PM
LOHR WALTER GDirectorFeb 15Option Exercise28.4910,578301,36718,831Feb 16 04:40 PM
SCHWIETERS JOHN TDirectorFeb 15Option Exercise28.4910,578301,36737,784Feb 16 04:47 PM
SCHWIETERS JOHN TDirectorFeb 15Sale84.2910,578891,62027,206Feb 16 04:47 PM
LOHR WALTER GDirectorFeb 15Sale84.3210,578891,9378,253Feb 16 04:40 PM
EHRLICH DONALD JDirectorFeb 14Option Exercise28.4910,578301,36795,378Feb 15 04:40 PM
EHRLICH DONALD JDirectorFeb 14Sale83.9810,578888,34084,800Feb 15 04:40 PM
COMAS DANIEL LEVP & CFOFeb 01Option Exercise19.8965,0001,292,850216,945Feb 03 04:33 PM
Joyce Thomas Patrick JRPresident and CEOFeb 01Option Exercise21.48196,3094,217,429329,466Feb 03 04:32 PM
Raskas DanielSVP-Corporate DevelopmentFeb 01Option Exercise28.5534,168975,49660,429Feb 03 04:33 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerFeb 01Option Exercise28.5534,168975,49665,015Feb 03 04:33 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerFeb 01Sale84.1034,1682,873,52930,847Feb 03 04:33 PM
Raskas DanielSVP-Corporate DevelopmentFeb 01Sale84.0034,1682,870,11226,261Feb 03 04:33 PM
Joyce Thomas Patrick JRPresident and CEOFeb 01Sale83.74196,30916,438,916169,282Feb 03 04:32 PM
COMAS DANIEL LEVP & CFOFeb 01Sale83.4965,0005,426,850151,945Feb 03 04:33 PM
Joyce Thomas Patrick JRPresident and CEOOct 21Option Exercise28.5536,1251,031,369205,407Oct 24 06:04 PM
Joyce Thomas Patrick JRPresident and CEOOct 21Sale79.6836,1252,878,296169,282Oct 24 06:04 PM
Joyce Thomas Patrick JRPresident and CEOAug 01Option Exercise28.5536,1251,031,369205,407Aug 02 06:07 PM
Joyce Thomas Patrick JRPresident and CEOAug 01Sale81.4445,8973,737,980169,282Aug 02 06:07 PM
COMAS DANIEL LEVP & CFOJul 27Option Exercise22.2696,4462,147,333259,270Jul 29 07:56 AM
COMAS DANIEL LEVP & CFOJul 27Sale80.8896,4467,800,332189,270Jul 29 07:56 AM
HEFNER LINDA PDirectorJul 11Option Exercise23.8810,578252,60320,197Jul 12 04:54 PM
Lalor Angela SSVP, Human ResourcesMay 12Sale97.778,392820,46148,110May 13 08:41 AM
SCHWIETERS JOHN TDirectorMay 06Option Exercise31.578,000252,56026,958May 09 05:36 PM
LICO JAMES AExecutive Vice PresidentApr 27Option Exercise37.7540,0001,510,000181,517Apr 29 07:27 AM
LICO JAMES AExecutive Vice PresidentApr 27Sale96.9358,9545,714,495122,563Apr 29 07:27 AM
Raskas DanielSVP-Corporate DevelopmentApr 22Option Exercise37.0724,300900,80141,524Apr 26 05:03 PM
DANIEL WILLIAM KEVPApr 22Option Exercise39.8226,1401,040,895164,785Apr 26 05:03 PM
COMAS DANIEL LEVP & CFOApr 22Option Exercise37.7589,2803,370,320230,978Apr 26 05:04 PM
COMAS DANIEL LEVP & CFOApr 22Sale95.7189,2808,545,015141,698Apr 26 05:04 PM
DANIEL WILLIAM KEVPApr 22Sale96.0641,1403,952,086123,645Apr 26 05:03 PM
Joyce Thomas Patrick JRPresident and CEOApr 22Sale95.5014,6301,397,165137,246Apr 26 05:04 PM
King WilliamSenior Vice PresidentApr 22Sale96.316,000577,86017,386Apr 26 05:02 PM
Raskas DanielSVP-Corporate DevelopmentApr 22Sale95.9524,3002,331,58517,224Apr 26 05:03 PM
WY Weyerhaeuser Co. daily Stock Chart
WY [NYSE]
Weyerhaeuser Co.
IndexS&P 500 P/E62.98 EPS (ttm)0.53 Insider Own0.10% Shs Outstand749.00M Perf Week-0.21%
Market Cap24.81B Forward P/E24.98 EPS next Y1.33 Insider Trans-10.60% Shs Float740.58M Perf Month-0.66%
Income393.00M PEG12.60 EPS next Q0.17 Inst Own80.20% Short Float2.17% Perf Quarter8.49%
Sales6.37B P/S3.90 EPS this Y-23.00% Inst Trans1.81% Short Ratio4.04 Perf Half Y5.28%
Book/sh12.26 P/B2.70 EPS next Y33.53% ROA4.80% Target Price34.95 Perf Year13.53%
Cash/sh0.90 P/C36.71 EPS next 5Y5.00% ROE10.60% 52W Range25.79 - 34.37 Perf YTD11.12%
Dividend1.24 P/FCF- EPS past 5Y-1.60% ROI4.80% 52W High-3.61% Beta1.36
Dividend %3.74% Quick Ratio1.00 Sales past 5Y0.50% Gross Margin22.60% 52W Low28.44% ATR0.57
Employees10400 Current Ratio1.30 Sales Q/Q26.10% Oper. Margin13.70% RSI (14)48.59 Volatility1.98% 1.69%
OptionableYes Debt/Eq0.78 EPS Q/Q-43.60% Profit Margin15.80% Rel Volume0.85 Prev Close33.47
ShortableYes LT Debt/Eq0.75 EarningsFeb 03 BMO Payout92.00% Avg Volume3.98M Price33.13
Recom1.90 SMA20-1.17% SMA502.21% SMA2007.35% Volume3,401,463 Change-1.02%
Jan-09-17Upgrade Raymond James Outperform → Strong Buy
Dec-15-16Downgrade CLSA Outperform → Underperform
Sep-22-16Initiated Goldman Buy $37
Aug-12-16Downgrade Dundee Buy → Neutral
Aug-08-16Downgrade DA Davidson Buy → Neutral $33
Jun-29-16Upgrade DA Davidson Neutral → Buy
May-09-16Downgrade DA Davidson Buy → Neutral $34 → $33
Feb-17-16Reiterated Argus Buy $43 → $28
Jan-19-16Upgrade Dundee Neutral → Buy
Nov-17-15Reiterated RBC Capital Mkts Outperform $37 → $35
Nov-13-15Upgrade Credit Agricole Underperform → Outperform
Sep-15-15Upgrade BofA/Merrill Neutral → Buy
Jul-16-15Downgrade BofA/Merrill Buy → Neutral
Jun-17-15Initiated Dundee Neutral $34
May-04-15Reiterated UBS Sell $29 → $27
Feb-17-15Reiterated Argus Buy $39 → $43
Nov-03-14Reiterated DA Davidson Buy $37 → $40
Aug-18-14Reiterated Argus Buy $36 → $39
Aug-04-14Upgrade DA Davidson Neutral → Buy $33 → $37
Apr-29-13Reiterated UBS Sell $20 → $24
Mar-25-17 02:43AM  [$$] Lumber Prices Headed Higher at Barrons.com
Mar-22-17 07:24PM  The One Place to Find 6.5% Dividends and 82% Upside Now at Forbes
Mar-10-17 04:53PM  WEYERHAEUSER CO Files SEC form 8-K, Entry into a Material Definitive Agreement
Mar-06-17 05:37AM  Weyerhaeuser (WY) Up 8.6% Since Earnings Report: Can It Continue?
Mar-02-17 01:04PM  WEYERHAEUSER CO Financials
Feb-23-17 04:30PM  Weyerhaeuser to present at the Raymond James 38th Annual Institutional Investors Conference PR Newswire
Feb-22-17 05:45PM  Cherry Street Public House opens in new Pioneer Square Weyerhaeuser building (Photos) at bizjournals.com
Feb-13-17 02:59PM  Weyerhauser Is Making an (Upside) Break For It
Feb-10-17 11:36AM  This Global Paper Giant Looks Promising
01:33AM  Weyerhaeuser Company declares dividend on common shares PR Newswire
Feb-08-17 11:21AM  Weyerhaeuser Co. :WY-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017
Feb-07-17 09:36AM  Weyerhaeuser Co. :WY-US: Earnings Analysis: Q4, 2016 By the Numbers : February 7, 2017
Feb-03-17 08:11PM  Edited Transcript of WY earnings conference call or presentation 3-Feb-17 3:00pm GMT
09:31AM  Weyerhaeuser (WY) Misses Q4 Earnings by a Penny; Sales Lag
07:25AM  Market Recon: The Fear of Stagflation Keeps Me Up at Night
07:07AM  Q4 2016 Weyerhaeuser Co Earnings Release - Before Market Open
06:02AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:00AM  Weyerhaeuser misses 4Q profit forecasts
04:40AM  Weyerhaeuser (WY) Misses on Q4 Earnings and Revenues
03:05AM  Weyerhaeuser reports fourth quarter, full year results PR Newswire
Feb-02-17 07:03PM  International Paper CEO explains what really triggered sh...
04:42PM  This Timber REIT Is a Solid Buy Amidst Spike in Housing, Construction
08:46AM  Why Earnings Season Could Be Great for Weyerhaeuser Company (WY)
08:10AM  Construction Stocks Reporting Q4 Earnings on Feb 3: WY, OSB
Feb-01-17 06:24AM  Weyerhaeuser's (WY) Q4 Earnings: Is a Beat in the Cards?
Jan-26-17 06:48AM  Great Lakes Announces Changes to Board of Directors GlobeNewswire
Jan-25-17 07:50AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : January 25, 2017
Jan-17-17 04:15PM  Weyerhaeuser announces tax treatment of 2016 distributions PR Newswire
Jan-09-17 08:25AM  Weyerhaeuser upgraded by Raymond James
Jan-06-17 11:40AM  U.S. makes early finding of injury from some softwood lumber from Canada Reuters
07:32AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : January 6, 2017
07:15AM  Weyerhaeuser's (WY) Long-Term Prospects Dimmed by Risks
Jan-03-17 04:49PM  Weyerhaeuser to release fourth quarter results on Feb. 3 PR Newswire
Dec-19-16 12:30PM  Federal Way mulls development moratorium after Weyerhaeuser campus deal falls through at bizjournals.com
Dec-17-16 08:25AM  3 Stocks to Buy With Dividends Yielding More Than 4% at Motley Fool
Dec-16-16 07:34AM  Weyerhaeuser Co. breached its 50 day moving average in a Bearish Manner : WY-US : December 16, 2016
Dec-14-16 10:20AM  5 Companies Hit 52-Week Highs
Dec-06-16 05:04PM  WEYERHAEUSER CO Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi
05:57AM  Trump's Policies Are Pushing These 5 Industrials Into Breakout Territory
Dec-04-16 09:34PM  Is Weyerhaeuser Co (WY) A Good Stock To Buy Right Now? at Insider Monkey
Dec-02-16 08:45AM  Weyerhaeuser Divests Cellulose Fibers Business for $2.2B
Dec-01-16 09:36AM  Weyerhaeuser completes sale of Cellulose Fibers pulp mills to International Paper PR Newswire
07:29AM  Weyerhaeuser Co. breached its 50 day moving average in a Bearish Manner : WY-US : December 1, 2016
Nov-29-16 10:02AM  Hate Checking Your Portfolio? Try These 3 Stocks at Motley Fool
Nov-24-16 12:12PM  Hilton Worldwide Holdings Inc (HLT): Are Hedge Funds Right About This Stock? at Insider Monkey
Nov-22-16 12:29PM  ETFs with exposure to Weyerhaeuser Co. : November 22, 2016
Nov-21-16 07:08AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : November 21, 2016
Nov-14-16 12:26PM  5 Top Construction Stocks for the Housing Rebound at Motley Fool
Nov-09-16 10:16AM  Four Global Natural Resource Plays That Are Attractive From the Long Side of the Charts
Nov-07-16 04:35PM  WEYERHAEUSER CO Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi
Nov-02-16 07:19AM  Weyerhaeuser Boosts Core Business with North Pacific Sale
Nov-01-16 04:30PM  Weyerhaeuser completes sale of printing papers business to an affiliate of One Rock Capital Partners PR Newswire
03:28PM  Paper: The Technology That Refuses To Die at Forbes
12:44PM  ETFs with exposure to Weyerhaeuser Co. : November 1, 2016
Oct-31-16 08:00PM  Weyerhaeuser announces leadership changes PR Newswire
05:55PM  RANKED: Highest-paid lobbying firms in Washington state and who's paying them at bizjournals.com
10:02AM  Weyerhaeuser Co. :WY-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016
06:30AM  Weyerhaeuser Stock Slips on Q3 Revenue Miss (WY) at Investopedia
Oct-29-16 02:21PM  Highlights From Third Avenues Investor Letters at Insider Monkey
Oct-28-16 01:01PM  Edited Transcript of WY earnings conference call or presentation 28-Oct-16 2:00pm GMT
09:02AM  Weyerhaeuser (WY) Beats Q3 Earnings, Lags on Revenues
07:07AM  Q3 2016 Weyerhaeuser Co Earnings Release - Before Market Open
06:03AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:03AM  Weyerhaeuser tops 3Q profit forecasts
04:01AM  Weyerhaeuser (WY) Beats on Q3 Earnings, Lags on Revenues
03:05AM  Weyerhaeuser reports third quarter results PR Newswire
Oct-27-16 04:00PM  Timber-r-r-r ... Lumber Plays Getting Felled
11:25AM  After second quarter payouts, International Paper posts strong third quarter at bizjournals.com
10:31AM  Weyerhaeuser Co. : WY-US: Dividend Analysis : October 28th, 2016 (record date) : By the numbers : October 27, 2016
07:50AM  Construction Stocks' Q3 Earnings to Watch on Oct 28: WY, GVA
Oct-26-16 08:11AM  Weyerhaeuser (WY) to Report Q3 Earnings: What to Expect?
Oct-25-16 08:35PM  Bill Bryant's top donors include Paccar CEO, Weyerhaeuser heir and Martin Selig at bizjournals.com
08:21PM  Gov. Jay Inslee's top donors include Mariners, Michael Bloomberg and Amazon execs at bizjournals.com
Oct-24-16 03:50PM  Weak industrial earnings, cause for concern?
Oct-20-16 06:42AM  Universal Forest (UFPI) Hikes Semi-Annual Dividend By 7%
Oct-18-16 08:12AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : October 18, 2016
Oct-14-16 05:16PM  Weyerhaeuser Company declares dividend on common shares PR Newswire
Oct-13-16 07:58AM  Weyerhaeuser (WY) to Strategically Review Assets in Uruguay
Oct-12-16 01:23PM  Traders turn bullish on Weyerhaeuser
08:50AM  [$$] Weyerhaeuser Explores Sale of Uruguay Business at The Wall Street Journal
07:07AM  Weyerhaeuser explores sale of Uruguay timber business
06:30AM  Weyerhaeuser to explore strategic alternatives for its Uruguay timberlands and manufacturing business PR Newswire
Oct-11-16 05:25PM  Weyerhaeuser shows off its new 'tree fort' headquarters in Seattle's Pioneer Square (Photos) at bizjournals.com
Oct-10-16 09:28AM  Weyerhaeuser's (WY) Growth Prospects Offset by Headwinds
Oct-06-16 10:19AM  Stock Market News for October 06, 2016
07:23AM  These 5 Big Stocks Are Breaking Out in October
06:58AM  Weyerhaeuser (WY) to Divest North Pacific to One Rock
Oct-05-16 10:24AM  [$$] Weyerhaeuser Sells Printing-Papers Business at The Wall Street Journal
08:31AM  Weyerhaeuser Co. breached its 50 day moving average in a Bearish Manner : WY-US : October 5, 2016
01:10AM  Weyerhaeuser to sell printing papers business to One Rock Capital Partners PR Newswire
Sep-30-16 04:30PM  Weyerhaeuser to release third quarter results on Oct. 28 PR Newswire
Sep-23-16 08:58AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : September 23, 2016
Sep-22-16 04:13PM  The Hot Stock: Weyerhaeuser Gains 5.7% Because That's the Power of Goldman Sachs at Barrons.com +5.74%
01:57PM  Reaction to Weyerhaeuser (WY) 'Buy' Rating at Goldman
12:35PM  Call of the day: Weyerhaeuser & SeaWorld
12:30PM  Goldman Neutral On Paper/Forest Products: Prefers Boise Cascade, Weyerhauser
08:55AM  Weyerhaeuser (WY) Stock Climbs, Gets 'Buy' Rating at Goldman
07:57AM  Early movers: AZO, RAD, CBS, SEAS, BBBY, YHOO, WCIC, JBL, RHT, LMT & more at CNBC
Sep-21-16 07:19PM  Cramer: Don't sweat it, this stock goes to $200 in the long run at CNBC
Sep-20-16 10:43AM  Strong Housing Starts And Chinese Demand Bode Well For Weyerhaeuser
Weyerhaeuser Co. is a real estate investment trust. It primarily invests in United States. The firm operates under four business segments, timberlands, wood products, cellulose fibers and real estate. It owns timberlands primarily in the U.S and has long-term licenses in Canada. The firm manufactures wood and specialty cellulose fibers products, and develops real estate, primarily as a builder of single-family homes. Weyerhaeuser Co was founded in 1900 and is based in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Merle Denise MSenior Vice PresidentMar 06Sale33.9473424,91234,621Mar 06 07:50 PM
Merle Denise MSenior Vice PresidentFeb 21Option Exercise24.165,150124,42441,335Feb 23 02:03 PM
Hunter Rhonda DSr. Vice PresidentFeb 21Option Exercise24.1614,099340,63288,510Feb 22 07:50 PM
Hunter Rhonda DSr. Vice PresidentFeb 21Sale34.0014,099479,36674,411Feb 22 07:50 PM
Merle Denise MSenior Vice PresidentFeb 21Sale34.005,150175,10036,185Feb 23 02:03 PM
Merle Denise MSenior Vice PresidentFeb 14Sale33.5237412,53636,185Feb 15 07:53 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerFeb 13Option Exercise28.1836,9341,040,89196,747Feb 15 07:17 PM
Merle Denise MSenior Vice PresidentFeb 13Sale33.281,34944,89636,559Feb 15 07:53 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerFeb 13Sale33.9036,9341,252,14059,134Feb 15 07:17 PM
Merle Denise MSenior Vice PresidentFeb 10Sale33.091,23340,80038,877Feb 14 03:33 PM
Hunter Rhonda DSr. Vice PresidentFeb 02Option Exercise30.392,19066,55261,406Feb 03 07:44 PM
Merle Denise MSenior Vice PresidentFeb 02Option Exercise30.395,176157,29336,735Feb 03 07:45 PM
Merle Denise MSenior Vice PresidentFeb 02Sale30.985,176160,35231,559Feb 03 07:45 PM
Hunter Rhonda DSr. Vice PresidentFeb 02Sale30.982,19067,84659,216Feb 03 07:44 PM
Hagen Russell SSenior Vice President and CFOJan 12Option Exercise25.279,600242,59289,763Jan 13 02:06 PM
Merle Denise MSenior Vice PresidentDec 08Option Exercise23.566,503153,19138,062Dec 12 06:54 PM
Merle Denise MSenior Vice PresidentDec 08Sale33.006,503214,59931,559Dec 12 06:54 PM
Merle Denise MSenior Vice PresidentOct 10Option Exercise18.3711,420209,73746,404Oct 12 06:12 PM
Merle Denise MSenior Vice PresidentOct 10Sale31.1215,049468,32531,355Oct 12 06:12 PM
Slater Catherine ISenior Vice PresidentAug 12Sale31.8111,609369,29470,466Aug 16 03:14 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 10Option Exercise16.8059,6861,002,921110,432Aug 11 07:31 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 10Sale32.5859,6861,944,52850,746Aug 11 07:31 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 09Option Exercise9.534,49242,80055,238Aug 10 08:28 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 09Sale32.504,492145,99050,746Aug 10 08:28 PM
Hunter Rhonda DSr. Vice PresidentJul 27Option Exercise23.563,31878,16261,768Jul 27 09:06 PM
Hunter Rhonda DSr. Vice PresidentJul 27Sale33.003,318109,49458,450Jul 27 09:06 PM
HOLLEY RICK RDirectorJul 26Option Exercise24.11181,0434,364,595735,113Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 26Sale32.64181,0435,909,092554,070Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 25Option Exercise24.41426,95710,423,885981,027Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 25Sale32.51426,95713,881,368554,070Jul 27 06:46 PM
Hunter Rhonda DSr. Vice PresidentJun 30Option Exercise20.423,29267,22361,742Jul 01 08:44 PM
Hunter Rhonda DSr. Vice PresidentJun 30Sale30.003,29298,76058,450Jul 01 08:44 PM
Hunter Rhonda DSr. Vice PresidentJun 20Sale29.126,500189,28058,019Jun 22 03:35 PM
Bozeman David PDirectorJun 09Sale30.301,92958,4566,262Jun 13 12:42 PM
Emmert Mark ADirectorJun 07Sale31.259,536298,0009,715Jun 08 07:56 PM
CELG Celgene Corporation daily Stock Chart
CELG [NASD]
Celgene Corporation
IndexS&P 500 P/E49.63 EPS (ttm)2.49 Insider Own0.20% Shs Outstand777.97M Perf Week-1.90%
Market Cap95.99B Forward P/E14.08 EPS next Y8.77 Insider Trans32.23% Shs Float775.96M Perf Month3.28%
Income2.00B PEG2.23 EPS next Q1.64 Inst Own79.90% Short Float1.02% Perf Quarter6.50%
Sales11.23B P/S8.55 EPS this Y28.10% Inst Trans1.47% Short Ratio1.92 Perf Half Y11.59%
Book/sh8.49 P/B14.53 EPS next Y21.33% ROA7.40% Target Price140.13 Perf Year22.72%
Cash/sh10.24 P/C12.04 EPS next 5Y22.28% ROE35.00% 52W Range94.42 - 127.64 Perf YTD6.59%
Dividend- P/FCF25.66 EPS past 5Y11.80% ROI11.70% 52W High-3.34% Beta1.78
Dividend %- Quick Ratio3.50 Sales past 5Y18.30% Gross Margin96.10% 52W Low30.67% ATR2.31
Employees7132 Current Ratio3.70 Sales Q/Q16.30% Oper. Margin25.00% RSI (14)53.38 Volatility1.73% 1.87%
OptionableYes Debt/Eq2.17 EPS Q/Q-22.20% Profit Margin17.80% Rel Volume0.69 Prev Close123.22
ShortableYes LT Debt/Eq2.09 EarningsApr 27 BMO Payout0.00% Avg Volume4.12M Price123.38
Recom1.80 SMA20-0.35% SMA503.54% SMA20010.58% Volume2,845,293 Change0.13%
Mar-09-17Initiated UBS Buy $140
Nov-09-16Downgrade Standpoint Research Buy → Hold
Nov-08-16Initiated Mizuho Buy $130
Jul-15-16Initiated Stifel Buy $138
Apr-29-16Reiterated Sun Trust Rbsn Humphrey Buy $145 → $147
Feb-25-16Initiated Citigroup Buy $130
Jan-20-16Initiated Credit Suisse Outperform
Jan-14-16Initiated Standpoint Research Buy $130
Jan-08-16Initiated Sun Trust Rbsn Humphrey Buy $145
Jan-07-16Initiated Sun Trust Rbsn Humphrey Buy
Nov-06-15Reiterated UBS Buy $156 → $145
Oct-01-15Upgrade JP Morgan Neutral → Overweight
Sep-09-15Initiated Jefferies Buy
Sep-01-15Initiated Raymond James Strong Buy $160
Jul-24-15Reiterated UBS Buy $142 → $156
Jul-24-15Reiterated JMP Securities Mkt Outperform $133 → $147
Jul-24-15Reiterated Cantor Fitzgerald Buy $146 → $163
Jul-21-15Reiterated Piper Jaffray Overweight $144 → $160
Jul-15-15Reiterated RBC Capital Mkts Outperform $135 → $150
Jul-15-15Reiterated Barclays Equal Weight $120 → $130
Mar-24-17 01:13PM  2 Asset Classes That Are Arguably Still Cheap at Motley Fool
Mar-22-17 09:30AM  Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen
07:37AM  A Look at Ionis Pharmaceuticals Spinraza
Mar-21-17 05:52PM  3 Value Stocks Senior Citizens Could Buy Right Now at Motley Fool
Mar-20-17 10:06AM  Why Biotech Stock Gilead (GILD) Could Be a Value Trap
09:50AM  Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now
09:17AM  Leerink Presents: Your 2017 Biopharma Catalyst Tracker
08:42AM  4 Stocks at 52-Week Highs That Are Still Worth Buying Today at Motley Fool
Mar-17-17 08:43AM  Celgene Corp. :CELG-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
Mar-16-17 07:08AM  [$$] Celgene Shows Savvy as Gilead Keeps Backsliding at Barrons.com
Mar-15-17 04:43PM  5 Things You Probably Didn't Know About Celgene Corporation at Motley Fool
04:29PM  Top Biotech Hits Buy Point As CEO Cites 'Momentum' In Key Drivers
Mar-14-17 11:08AM  Credit Suisse's Top 10 Stocks for 2017
10:35AM  Amgen's Repatha Meets Primary Endpoint in Phase III Study
Mar-12-17 02:57PM  Top Biotech May 'Unveil' Breakthrough Treatment And Breakout Move
Mar-10-17 04:41PM  Top Stocks Billionaires Are Buying Now at Motley Fool
04:39PM  Under-The-Radar Biotech Tests Buy Zone; Cancer Trial Results 'Encouraging'
11:30AM  Epizyme (EPZM) Reports Narrower Q4 Loss, Pipeline in Focus
10:30AM  Major Biotechs See a Retreat in Short Interest
09:03AM  The 3 Drugs Powering Celgene to the Top of Your Portfolio at Motley Fool
Mar-09-17 06:32PM  Top Research Reports for March 9, 2017
04:03PM  Will Pfizer Take On Celgene, Other Rivals With Leukemia Drug?
01:57PM  Celgene's Deep Pipeline Can Reassure Investors
01:40PM  Drugs, travel, jewelry and social media in the blitz
10:00AM  Coverage initiated on Celgene by UBS
09:03AM  5 Reasons Celgene Will Be a Top Biotech Stock for the Next Decade at Motley Fool
Mar-08-17 05:17PM  Valeant (VRX) Issues Notes, Restructures Debt; Shares Down
04:55PM  Seattle Genetics (SGEN): FDA Lifts Hold on Trial of AML Drug
09:45AM  Ionis Pharma Lipid Disorder Candidate Positive in Phase III
09:32AM  3 Safe Stocks You Can Buy Right Now at Motley Fool
08:18AM  Biotech Stock Roundup: Trump Tweet Hits Biotech Stocks, Concert Gains on Vertex Deal
Mar-07-17 04:08PM  GlaxoSmithKline's Nucala Positive in Label Expansion Study
03:58PM  Biotech beat up?
03:04PM  3 Biotech Stocks You Don't Have to Babysit at Motley Fool
09:48AM  Trump's Latest Drug Pricing Tweet Hits Biotech Stocks at The Wall Street Journal
08:04AM  Here's Why the Best Is Yet to Come for Gilead Sciences, Inc. at Motley Fool
Mar-06-17 10:20AM  Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy
08:41AM  J&J Presents Positive Phase III Data on Psoriasis Candidate
Mar-05-17 12:35PM  Celgene Announces Oral OTEZLA Demonstrated Significant Improvement vs Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy
08:55AM  Oral OTEZLA® (Apremilast) Demonstrated Significant Improvement versus Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy Business Wire
Mar-04-17 10:52AM  How to Profit from Celgene (CELG) Options
06:42AM  Bad News Biotechs: What's Next for Juno and PTC Therapeutics? at Motley Fool
Mar-03-17 07:00PM  A Remarkable Approach to Profit from Celgene Options
09:32AM  Nektar Therapeutics (NKTR) Loss Wider than Expected in Q4
07:00AM  Celgene to Present New Data from Clinical Trials on Oral OTEZLA® (apremilast) at American Academy of Dermatology Congress Business Wire
Mar-02-17 07:37PM  Why Juno Therapeutics Inc. Tanked on Thursday at Motley Fool
05:08PM  Merrimack (MACK) Q4 Loss Lower than Expected, Revenues Top
03:21PM  Why Celgene's Shares Rallied Higher in February at Motley Fool
09:57AM  Geron (GERN) Q4 Loss Narrows; Focus Remains on Imetelstat
09:50AM  Billionaire George Soros Bought These 2 Biotech Stocks at Motley Fool
09:30AM  Zacks Industry Outlook Highlights: GlaxoSmithKline, Celgene and Exelixis
Mar-01-17 06:03PM  Juno Therapeutics' Q4 Financial Results Overshadowed by Pipeline Setback at Motley Fool
05:09PM  Juno ends development of high-profile leukemia drug after deaths
03:19PM  M&As, Pipeline Catalysts to Drive Pharma Sector
03:15PM  Agios CEO touts path from 'a blank piece of paper' to cusp of drug approval at bizjournals.com
10:37AM  Regeneron Could See a Modest Rise in Net Profit Margins in 2017
10:04AM  [$$] Cancer Test Makers Raise Nearly $1 Billion at The Wall Street Journal
09:37AM  Medicines Company (MDCO) Q4 Loss Narrower than Expected
08:36AM  Why Is Celgene (CELG) Up 6% Since the Last Earnings Report?
08:06AM  Carl Icahn Takes Aim at Bristol-Myers Squibb at Motley Fool
07:30AM  FDA Accepts New Drug Application and Grants Priority Review for Enasidenib in Relapsed or Refractory AML with an IDH2 Mutation Business Wire
07:24AM  Biotech Stock Roundup: Kite Soars on CAR-T Data, EXEL in Immuno-Oncology Deals
Feb-28-17 05:54PM  Why Gileads Valuation Is Low Compared to Peers
12:17PM  Endo (ENDP) Beats on Q4 Earnings, Revenues; Guides Low
12:15PM  Horizon (HZNP) Misses on Earnings in Q4, View Disappoints
10:15AM  Short Sellers Hike Their Bets in Major Biotechs
09:27AM  Smart Investors Are Already Buying These Stocks for Retirement at Motley Fool
09:24AM  Perrigo to Sell Tysabri Royalties; Issues Tepid 2017 View
Feb-27-17 08:23AM  Achillion (ACHN) Reports Narrower-Than-Expected Q4 Loss
07:37AM  Why Vertex Expects Its Profit Margin to Rise in 2017
07:30AM  Celgene Corporation to Webcast at Upcoming Investor Conferences Business Wire
Feb-24-17 03:25PM  Emergent (EBS) Beats Earnings, Revenue Estimates in Q4
01:45PM  Is There More Than Meets the Eye on Celgenes President, COO Retirement?
10:57AM  3 Incredibly Cheap Biotech Stocks at Motley Fool
05:43AM  REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma after Autologous Stem Cell Transplantation Business Wire
Feb-23-17 05:36PM  CELGENE CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
04:30PM  Celgene Announces Retirement of President and Chief Operating Officer, Jacqualyn Fouse, Ph.D. and Promotion of Scott Smith to President and Chief Operating Officer Business Wire
02:20PM  Celgenes Revlimid Secures Label Expansion at Investopedia
08:02AM  Here's Why Celgene's Latest Drug Is So Exciting at Motley Fool
Feb-22-17 04:02PM  FDA Expands Indication for REVLIMID® (lenalidomide) as a Maintenance Treatment for Patients with Multiple Myeloma Following Autologous Hematopoietic Stem Cell Transplant (auto-HSCT) Business Wire
06:43AM  Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising
Feb-21-17 07:01PM  3 Great Stocks to Buy Instead of NVIDIA Corporation at Motley Fool
08:15AM  Blog Coverage Celgene's Multiple Sclerosis Drug Reported Positive Phase-III Results Accesswire
06:00AM  [$$] US exporters line up behind tax code overhaul at Financial Times
Feb-20-17 10:30AM  Celgene MS Drug Reports Positive Phase 3 Data at Investopedia
08:24AM  3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter at Motley Fool
07:52AM  Forget Alexion, Buy these 4 Biotech Stocks Instead
Feb-19-17 11:41AM  Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands? at Motley Fool
Feb-17-17 04:15PM  Celgene MS Drug Wins In Trial; Will Safety Top Novartis, Biogen?
01:30PM  Stocks Quietly Mixed In Afternoon; Skyworks Breaks Out, Celgene Bases
08:39AM  Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial
08:14AM  CELGENE CORP /DE/ Files SEC form 8-K, Other Events
07:30AM  Celgene Announces Positive Results from Phase III SUNBEAM Trial of Oral Ozanimod in Patients with Relapsing Multiple Sclerosis Business Wire
Feb-16-17 02:39PM  3 Biotechs With Tremendously Promising Pipelines at Motley Fool
08:53AM  Agios (AGIO) Q4 Loss Narrower than Expected; Revenues Up Y/Y
Feb-15-17 06:35PM  Cramer fires back at naysayers: Here's your proof that th...
06:22PM  Cramer fires back at naysayers: Here's your proof that this rally is real at CNBC
05:59PM  Proof the rally is real
01:04PM  CELGENE CORP /DE/ Financials
10:56AM  Celgene Could Have One More Powerful Move Higher
Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis, psoriasis, and ankylosing spondylitis; and ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers. The company's products also include VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and acute myeloid leukemia (AML); THALOMID to treat patients with multiple myeloma and erythema nodosum leprosum; and RITALIN and FOCALIN XR products. Its clinical stage products comprise OTEZLA for use in treating various immune-inflammatory diseases; luspatercept for beta-thalassemia and MDS; CC-486 to treat MDS, AML, and solid tumors; AG-881 for glioma with IDH mutations; LSD1 inhibitor to treat non-hodgkin lymphoma and solid tumors; CC-122 and CC-220 to treat hematological and solid tumor cancers, and inflammation and immunology diseases; and durvalumab, an anti-PDL-1 antibody, for multiple hematological cancers. The company has collaborative agreements with Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; Sutro Biopharma, Inc.; bluebird bio, Inc.; FORMA Therapeutics Holdings, LLC; OncoMed Pharmaceuticals, Inc.; NantBioScience, Inc.; AstraZeneca PLC; Lycera Corp.; Juno Therapeutics, Inc.; Nurix Inc.; and Jounce Therapeutics, Inc.; The company was founded in 1980 and is headquartered in Summit, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KAPLAN GILLADirectorMar 03Option Exercise25.587,500191,81387,142Mar 07 04:37 PM
VESSEY RUPERTSee remarksMar 01Sale124.424,000497,672778Mar 02 04:04 PM
CASEY MICHAEL DDirectorFeb 27Option Exercise25.587,500191,8507,500Mar 01 04:15 PM
CASEY MICHAEL DDirectorFeb 27Sale121.557,500911,6250Mar 01 04:15 PM
VESSEY RUPERTSee remarksFeb 02Option Exercise0.005,62306,773Feb 06 04:14 PM
Celgene Switzerland LLC10% OwnerFeb 01Buy16.00625,00010,000,0003,456,463Feb 01 04:18 PM
HUGIN ROBERT Jsee remarksJan 05Option Exercise27.4322,708622,767913,909Jan 09 04:11 PM
Smith Scott AndrewSee RemarksDec 23Option Exercise0.006,400039,875Dec 27 04:17 PM
PEHL MICHAEL F.See remarksDec 02Option Exercise0.001,88001,880Dec 06 04:05 PM
Smith Scott AndrewSee RemarksDec 02Option Exercise0.003,750035,419Dec 06 04:05 PM
FOUSE JACQUALYN Asee remarksDec 02Option Exercise0.005,000084,392Dec 06 04:04 PM
Alles Mark JSee RemarksDec 02Option Exercise0.006,5600166,134Dec 06 04:03 PM
VESSEY RUPERTSee remarksNov 22Sale123.182,500307,9501,150Nov 30 04:15 PM
PEHL MICHAEL F.See remarksNov 10Option Exercise68.3920,4241,396,77022,052Nov 15 04:22 PM
PEHL MICHAEL F.See remarksNov 10Sale121.0422,0522,669,1490Nov 15 04:22 PM
Friedman Michael ADirectorNov 09Option Exercise31.8018,600591,48018,600Nov 10 04:14 PM
Friedman Michael ADirectorNov 09Sale116.1018,6002,159,4600Nov 10 04:14 PM
HUGIN ROBERT Jsee remarksNov 09Sale120.00100,00012,000,000922,201Nov 14 05:47 PM
CELGENE CORP /DE/10% OwnerOct 24Buy14.00800,15011,202,1004,834,980Oct 26 04:15 PM
CASEY MICHAEL DDirectorOct 18Option Exercise100.067,500750,45092,985Oct 19 04:16 PM
Friedman Michael ADirectorOct 03Option Exercise29.8656,1161,675,36456,116Oct 05 04:09 PM
Friedman Michael ADirectorOct 03Sale103.6656,1165,816,9850Oct 05 04:09 PM
BARKER RICHARD WDirectorSep 23Option Exercise36.9220,000738,40031,332Sep 26 04:08 PM
BARKER RICHARD WDirectorSep 23Sale110.8220,0002,216,40011,332Sep 26 04:08 PM
MARIO ERNESTDirectorSep 23Sale109.4215,0001,641,30090,058Sep 26 04:08 PM
KAPLAN GILLADirectorSep 19Option Exercise29.267,500219,45079,642Sep 20 04:42 PM
KAPLAN GILLADirectorSep 15Sale106.449,7101,033,53272,142Sep 16 04:15 PM
LOUGHLIN JAMES JDirectorAug 23Option Exercise26.3627,500724,85050,419Aug 24 04:28 PM
LOUGHLIN JAMES JDirectorAug 23Sale114.1027,5003,137,75022,919Aug 24 04:28 PM
CASEY MICHAEL DDirectorAug 22Sale114.0143,1344,917,70785,485Aug 23 04:29 PM
HUGIN ROBERT Jsee remarksJul 28Sale110.00100,00011,000,0001,022,201Aug 01 05:04 PM
MARIO ERNESTDirectorJul 01Option Exercise0.007330105,058Jul 05 04:32 PM
LOUGHLIN JAMES JDirectorJul 01Option Exercise0.00733022,919Jul 05 04:30 PM
Friedman Michael ADirectorJul 01Option Exercise0.0073300Jul 05 04:27 PM
KAPLAN GILLADirectorJul 01Option Exercise0.00733081,852Jul 05 04:28 PM
COX CARRIE SMITHDirectorJul 01Option Exercise0.00733023,146Jul 05 04:27 PM
BARKER RICHARD WDirectorJul 01Option Exercise0.00733011,551Jul 05 04:25 PM
CASEY MICHAEL DDirectorJul 01Option Exercise0.0073300Jul 05 04:26 PM
HUGIN ROBERT Jsee remarksJun 20Sale100.1675,0007,512,0001,122,201Jun 22 04:42 PM
KAPLAN GILLADirectorJun 17Option Exercise0.00333081,119Jun 17 04:18 PM
CASEY MICHAEL DDirectorJun 17Option Exercise0.0033300Jun 17 04:13 PM
Friedman Michael ADirectorJun 17Option Exercise0.0033300Jun 17 04:14 PM
MARIO ERNESTDirectorJun 16Option Exercise0.002,0550113,892Jun 16 06:57 PM
COX CARRIE SMITHDirectorJun 16Option Exercise0.006,200022,413Jun 17 04:14 PM
KAPLAN GILLADirectorJun 15Option Exercise0.006,200080,786Jun 17 04:18 PM
LOUGHLIN JAMES JDirectorJun 12Option Exercise0.002,068021,853Jun 13 05:10 PM
MARIO ERNESTDirectorJun 12Option Exercise0.002,0680103,992Jun 13 05:10 PM
KAPLAN GILLADirectorJun 12Option Exercise0.002,068074,586Jun 13 05:09 PM
BARKER RICHARD WDirectorJun 12Option Exercise0.002,068011,439Jun 13 05:08 PM
CASEY MICHAEL DDirectorJun 12Option Exercise0.002,06800Jun 13 05:08 PM
Friedman Michael ADirectorJun 12Option Exercise0.002,06800Jun 13 05:09 PM
Alles Mark JSee RemarksApr 29Option Exercise0.0011,0000164,636May 03 04:30 PM
HUGIN ROBERT Jsee remarksApr 29Option Exercise0.0060,00001,228,311May 03 04:19 PM
Smith Scott AndrewSee RemarksApr 29Option Exercise0.0010,000036,656May 03 09:28 PM
MARIO ERNESTDirectorApr 26Option Exercise31.805,000158,975101,924Apr 28 04:09 PM
KAPLAN GILLADirectorApr 04Sale101.8415,9671,626,07972,518Apr 05 04:15 PM
CVS CVS Health Corporation daily Stock Chart
CVS [NYSE]
CVS Health Corporation
IndexS&P 500 P/E15.93 EPS (ttm)4.93 Insider Own0.20% Shs Outstand1.03B Perf Week-0.49%
Market Cap80.51B Forward P/E12.30 EPS next Y6.38 Insider Trans-11.91% Shs Float1.02B Perf Month-2.93%
Income5.29B PEG1.52 EPS next Q1.10 Inst Own86.50% Short Float3.20% Perf Quarter-1.11%
Sales177.53B P/S0.45 EPS this Y5.60% Inst Trans-0.73% Short Ratio4.75 Perf Half Y-12.38%
Book/sh34.61 P/B2.27 EPS next Y8.87% ROA5.70% Target Price86.52 Perf Year-21.09%
Cash/sh3.37 P/C23.28 EPS next 5Y10.46% ROE14.70% 52W Range68.88 - 105.04 Perf YTD0.07%
Dividend2.00 P/FCF13.41 EPS past 5Y13.60% ROI9.90% 52W High-25.28% Beta0.84
Dividend %2.55% Quick Ratio0.60 Sales past 5Y10.60% Gross Margin16.30% 52W Low13.95% ATR0.90
Employees158000 Current Ratio1.20 Sales Q/Q11.70% Oper. Margin5.50% RSI (14)37.03 Volatility0.93% 1.11%
OptionableYes Debt/Eq0.75 EPS Q/Q17.90% Profit Margin3.00% Rel Volume0.56 Prev Close78.30
ShortableYes LT Debt/Eq0.70 EarningsFeb 09 BMO Payout34.30% Avg Volume6.90M Price78.49
Recom2.00 SMA20-2.07% SMA50-1.57% SMA200-8.17% Volume3,878,542 Change0.24%
Feb-06-17Downgrade Atlantic Equities Overweight → Neutral
Feb-02-17Downgrade Robert W. Baird Outperform → Neutral $86 → $77
Dec-12-16Downgrade Jefferies Buy → Hold
Nov-09-16Reiterated Mizuho Buy $111 → $90
Aug-04-16Reiterated Mizuho Buy $108 → $111
Aug-03-16Reiterated Deutsche Bank Hold $99 → $108
Jun-23-16Reiterated Mizuho Buy $117 → $108
Jun-22-16Reiterated Deutsche Bank Hold $105 → $99
Jun-20-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-04-16Reiterated RBC Capital Mkts Outperform $110 → $115
May-04-16Reiterated Mizuho Buy $104 → $117
Mar-10-16Reiterated Barclays Overweight $110 → $115
Feb-10-16Reiterated Mizuho Buy $113 → $104
Feb-03-16Initiated Atlantic Equities Overweight
Jan-22-16Initiated Robert W. Baird Outperform $108
Dec-18-15Resumed Barclays Overweight $110
Dec-17-15Reiterated Oppenheimer Outperform $115 → $117
Dec-17-15Downgrade Goldman Buy → Neutral
Aug-28-15Reiterated Oppenheimer Outperform $122 → $119
Aug-10-15Reiterated Argus Buy $114 → $118
Mar-25-17 06:00AM  Keller Rohrback L.L.P. Files Class-Action Lawsuit Over the Inflated Price of Insulin Business Wire
Mar-24-17 12:47PM  19 Retailers Are Shedding Stores So Far in 2017 at Investopedia
09:00AM  16 Large Retailers Besides J.C. Penney Are Closing Waves of Stores
Mar-23-17 06:29PM  CVS Lease-Backed Pass-Through Certificates, Series 2003-1 -- Moody's Affirms 12 CVS Lease Backed Certificates at Moody's
03:37PM  CVS Credit Lease Backed Pass-Through Certificates, Series A-1 and Series A-2 -- Moody's Affirms the CTL Rating of CVS Credit Lease Backed Pass-Through Certificates, Series A-1 and Series A-2 at Moody's
08:30AM  CVS Health, University of Pittsburgh School of Pharmacy and Pittsburgh Public Schools Announce Joint Effort to Prevent Youth Drug Abuse PR Newswire
Mar-22-17 01:04PM  Retail CFOs Expect 5% Sales Growth This Year at Investopedia
09:42AM  Pharmacy Benefit Managers and Insulin Makers Face Price Scheme Lawsuit at Investopedia
08:50AM  Partisan Politics May Be To Blame For Hold Up In Walgreens-Rite Aid Deal
Mar-21-17 07:09PM  Here's How I Invest My Own Retirement Cash at Forbes
03:04PM  Rite Aid Stock Could Dive 53% If Walgreens Deal Fails: Deutsche Bank
Mar-20-17 02:55PM  Is The Market Expensive? Buffett Says No at Forbes
10:08AM  Better Buy: CVS Health Corporation vs. Wal-Mart Stores at Motley Fool
Mar-17-17 01:03PM  CVS Health says Amgen data may increase eligible patients by millions
10:48AM  CVS Health Corp. : CVS-US: Dividend Analysis : January 24th, 2017 (record date) : By the numbers : March 17, 2017
09:18AM  CVS Health Launches Reduced Rx for Affordable Medication
Mar-16-17 05:50PM  Billionaire investor: Not pulling money out of markets, just applying great caution at CNBC
08:20AM  CVS Health Launches Reduced Rx Savings Program to Give Patients Access to More Affordable Medications PR Newswire
07:05AM  CVS Health (CVS) Up 4% Since Earnings Report: Can It Continue?
Mar-15-17 04:35PM  Express Scripts Downgraded On Fear It Could Lose Anthem Contract
11:16AM  Walgreens to Sell Assets to Acquire Rite Aid at Investopedia
08:31AM  The 5 Best Dividend Stocks of 2027 at Motley Fool
08:30AM  CVS Health PBM Clients Achieved Lowest Prescription Drug Trend in Four Years, Despite Rising Drug Prices PR Newswire
Mar-14-17 07:50PM  Longs Drugs to open another pharmacy at Ala Moana Center at bizjournals.com
05:25PM  Twitter, Alphabet, Yahoo Among First Pacific's Recent Investments
01:55PM  CVS Health Corp (CVS) Pledges Funds For Youth Anti-Smoking Campaign at Insider Monkey
Mar-13-17 06:19PM  Arnold Van Den Berg Invests in 4 New Buys in 4th Quarter
08:30AM  CVS Health Takes Next Step in Five-Year Commitment to Deliver the First Tobacco-Free Generation PR Newswire
Mar-12-17 06:42AM  3 Healthcare Stocks That Are Looking Cheap at Motley Fool
Mar-11-17 10:15AM  3 Incredibly Cheap Dividend Stocks at Motley Fool
Mar-10-17 02:24PM  Access For Reversal Drug For Opioid Overdose Expanded By CVS Health Corp (CVS) at Insider Monkey
Mar-09-17 08:30AM  CVS Health Expands Access to Opioid Overdose-Reversal Drug at CVS Pharmacy locations in Arizona, Georgia, Iowa and South Carolina PR Newswire
Mar-08-17 04:08PM  Pioneer Investments Boosts JPMorgan, BlackRock, Comcast
03:55PM  Did The CIA Clear The Way For High-Profile Cyber Attacks?
10:43AM  Uber CEO Travis Kalanick Is Looking for a Deputy at Investopedia
Mar-07-17 03:30PM  Fred's adds three industry veterans to board at bizjournals.com
Mar-06-17 04:21PM  [$$] Alliance of Companies Unveil First Steps to Cutting Health-Care Costs at The Wall Street Journal
11:09AM  6 Stocks That Will Get a Boost From a Trump Tax Cut
08:06AM  CVS Health Adopts Epic EHR for Specialty Care Programs
Mar-04-17 02:07PM  3 Companies That Could Win Big With Trump Tax Reform at Motley Fool
Mar-03-17 12:00PM  CVS Health To Present At The Barclays Global Healthcare Conference PR Newswire
11:39AM  CVS Health Corp (CVS) Specialty Turns To New Record System For More Efficiency at Insider Monkey
09:02AM  What's the Right Prescription for This Ailing Drug Store? at Motley Fool
Mar-02-17 05:02PM  CVS HEALTH CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
03:30PM  CVS Health Names Jon Roberts Executive Vice President and Chief Operating Officer PR Newswire
10:23AM  CVS Health Corporation Announces Quarterly Dividend PR Newswire
08:30AM  CVS Health to Adopt Epic Electronic Health Record System for CVS Specialty Care Management Programs PR Newswire
Mar-01-17 04:41PM  The Biggest Loser: Envision Healthcare Tumbles 6.3% at Barrons.com
08:15AM  Post Earnings Coverage as CVS' Quarterly Revenue Increased 11.7%, Adjusted EPS Advanced Approximately 12% Accesswire
Feb-28-17 10:30AM  CVS Health Corporation's Executive Vice President and CFO Dave Denton interviewed by Advisor Access Marketwired
09:30AM  Top Analyst Upgrades and Downgrades: Apple, CVS Health, Priceline, Teva Pharmaceuticals, Workday and Many More
Feb-27-17 08:00AM  This Is What Everyone Demands to Know From Struggling Target
Feb-24-17 12:57PM  3 Cheap Healthcare Stocks You Can Buy Right Now at Motley Fool
08:00AM  More States Lift Patient Hurdles To Nurse Practitioners at Forbes
Feb-23-17 09:23PM  3 of the Safest Stocks You Can Buy Right Now at Motley Fool
10:25AM  Banks and retailers reignite the debit card fee war. It's hard to know who to root for
Feb-22-17 11:50AM  Here are the winners and losers under President Trump's first month
09:31AM  CVS removes artificial trans fats from its food brands Reuters
08:53AM  CVS says it has removed artificial trans fat contributor from all exclusive store brands, in advance of mid-2018 deadline at MarketWatch
08:40AM  CVS Pharmacy Is First National Retail Pharmacy to Remove Artificial Trans Fats from All Exclusive Store Brand Food Products PR Newswire
08:15AM  Post Earnings Coverage as Express Scripts' Adjusted EPS Gained 21%; Adjusted EBITDA per Adjusted Claim up 14% Accesswire
Feb-17-17 12:27PM  It Has Worked: CVS Health Corp (CVS) Says Of Its Exit Of Cigarette Business at Insider Monkey
Feb-16-17 04:29PM  CVS Health And Breathe California Announce Statewide Finalists In Student Film Contest On Youth Smoking PR Newswire
04:01PM  CVS Health Research Institute Study Confirms that the Company's Tobacco Removal Decision Reduced Cigarette Purchases Nationwide PR Newswire
01:49PM  The Experts Say You Should Buy These Stocks. So Should You? at Insider Monkey
12:23PM  2 Stocks To Buy And Hold For The Next 2 Years at Forbes
10:23AM  FORTUNE® Recognizes CVS Health on List of "World's Most Admired Companies" PR Newswire
08:39AM  3 Bargain Stocks You Can Buy Today at Motley Fool
Feb-15-17 03:52PM  Hill: GD & CVS will benefit from Trump administration
01:04PM  CVS HEALTH CORP Financials
12:02PM  Express Scripts: Rx For Earnings Growth
08:23AM  4 Stocks to Buy Near 52-Week Lows at Motley Fool
Feb-14-17 07:26PM  George Soros Builds Stake in Goldman Sachs, Cuts BofA at The Wall Street Journal
04:13PM  Better Buy: CVS Health Corporation vs. Express Scripts at Motley Fool
03:37PM  ETFs with exposure to CVS Health Corp. : February 14, 2017
11:45AM  Headline Risk Haunts PBMs As Drug Pricing Debate Intensifies
10:41AM  "Made in the USA" lawsuit against CVS Health is dismissed
Feb-13-17 10:43AM  CVS Health Corp. :CVS-US: Earnings Analysis: 2016 By the Numbers : February 13, 2017
09:30AM  CVS Health Earns CEO Cancer Gold Standard Accreditation PR Newswire
08:00AM  MinuteClinic to Offer Free "Know Your Numbers" Screenings on Valentine's Day at Locations Nationwide PR Newswire
Feb-10-17 03:46PM  5 Things CVS Health Management Said That You'll Want to Know at Motley Fool
03:12PM  Two Dozen Dividend Growth Superstar Stocks That Look Cheap at Forbes
09:08AM  CVS Health Corp. :CVS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 10, 2017
08:45AM  PBMs are able to negotiate on drug prices: Dave Dorman
Feb-09-17 06:15PM  Edited Transcript of CVS earnings conference call or presentation 9-Feb-17 1:30pm GMT
05:32PM  WellDyneRx, LLC -- Moody's affirms WellDyneRx's first lien bank rating at B3; Caa1 CFR at Moody's
04:03PM  CVS Health Earnings Growth Tops, But Sales Miss Estimates
02:48PM  CVS Remains Unsure About the Future of Obamacare, CEO Says
01:25PM  What Is Driving CVS Revenue Growth?
01:22PM  [$$] CVS Profit Rises, Helped by Pharmacy Strength at The Wall Street Journal
01:05PM  CVS Health Tops Expectations in Q4 Thanks to CareMark PBM at Motley Fool
12:26PM  CVS defends PBM industry against drug price hikes
12:02PM  CVS Health beats 4Q profit forecasts, affirms 2017 forecast
10:03AM  Pharmacy Services Boost CVS Amid Drug Pricing Battle at Forbes
09:50AM  CVS Health (CVS) Beats on Q4 Earnings, Retains '17 View
09:14AM  5 Stocks For 17% Returns This Year (& Beyond) at Forbes
08:28AM  CVS Health Tops Q4 Earnings, Misses on Revenues
08:26AM  Market Recon: This Barbarous Relic Has Been Seriously Hot Lately
07:51AM  Early movers: KO, TWTR, VIAB, CVS, YUM, RAI, & more at CNBC
07:12AM  CVS shares gain 2% after Q4 profit beats expectations at MarketWatch
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2016, it had 23 retail specialty pharmacy stores, 13 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 84 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,709 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y mas, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 38 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brennan Troyen AEVP and Chief Medical OfficerMar 21Option Exercise45.0716,637749,83094,309Mar 22 04:20 PM
Brennan Troyen AEVP and Chief Medical OfficerMar 21Sale78.7323,8491,877,63270,460Mar 22 04:20 PM
Boratto Eva CEVP, Cont & Chief Acct OfficerMar 17Option Exercise34.966,029210,77441,614Mar 20 04:24 PM
Boratto Eva CEVP, Cont & Chief Acct OfficerMar 17Sale79.606,029479,90835,585Mar 20 04:24 PM
Sussman AndrewEVP, Clinical ServicesMar 13Option Exercise45.076,655299,94122,801Mar 14 04:21 PM
Sussman AndrewEVP, Clinical ServicesMar 13Sale80.4014,1041,133,9628,697Mar 14 04:21 PM
Denton David MEVP and CFOMar 10Option Exercise36.2395,6183,464,240250,335Mar 13 04:11 PM
Denton David MEVP and CFOMar 10Sale80.6895,6187,714,460154,717Mar 13 04:11 PM
Roberts Jonathan CEVP & President, CVS CaremarkFeb 16Option Exercise36.2361,1962,217,13189,955Feb 17 04:10 PM
Roberts Jonathan CEVP & President, CVS CaremarkFeb 16Sale80.0061,1964,895,68028,759Feb 17 04:10 PM
MERLO LARRY JPresident and CEOFeb 01Option Exercise36.2376,4942,771,378318,706Feb 03 04:11 PM
MERLO LARRY JPresident and CEOFeb 01Sale78.3276,4945,991,010242,212Feb 03 04:11 PM
MERLO LARRY JPresident and CEOMay 05Option Exercise36.2338,2471,385,689280,381May 06 04:26 PM
GOLD STEPHEN JEVP & CIOMay 05Option Exercise47.299,798463,34731,358May 06 04:29 PM
GOLD STEPHEN JEVP & CIOMay 05Sale105.009,7981,028,79021,560May 06 04:29 PM
Brennan Troyen AEVP and Chief Medical OfficerMay 05Sale105.007,517789,28569,601May 06 04:28 PM
MERLO LARRY JPresident and CEOMay 05Sale105.0038,2474,015,935242,134May 06 04:26 PM
GOLD STEPHEN JEVP & CIOApr 01Option Exercise47.2921,9221,036,69142,048Apr 05 06:39 PM
Sussman AndrewEVP & Pres, CVS MinuteClinicApr 01Sale105.002,844298,62011,041Apr 05 07:21 PM
GOLD STEPHEN JEVP & CIOApr 01Sale105.0021,9222,301,81020,126Apr 05 06:39 PM
XLV  The Health Care Select Sector SPDR Fund daily Stock Chart
XLV [NYSE]
The Health Care Select Sector SPDR Fund
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.16%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month0.19%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter8.29%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio2.89 Perf Half Y2.11%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year12.00%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range65.43 - 76.47 Perf YTD8.15%
Dividend1.11 P/FCF- EPS past 5Y- ROI- 52W High-2.85% Beta-
Dividend %1.49% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low13.53% ATR0.75
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)51.11 Volatility1.45% 0.91%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.99 Prev Close74.25
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume9.29M Price74.29
Recom- SMA20-1.12% SMA502.17% SMA2004.29% Volume9,210,574 Change0.05%
Mar-25-17 06:52AM  GOP health bill goes down, but Trump can still unleash HHS to bedevil Obamacare at MarketWatch
Mar-24-17 04:39PM  Trump Pulls the Healthcare Bill; Market Feels the Pain at Barrons.com
02:56PM  5 Biggest Winners from the Obamacare Replacement Bill Pushback
02:23PM  "No" on AHCA Good for Hospital Stocks? at Barrons.com
01:02PM  Today's charts: Investors track health care stocks ahead of vote on new bill
12:58PM  Healthcare: Will They or Won't They? at Barrons.com
12:23PM  [$$] Health-Care Investors Are Too Complacent at The Wall Street Journal
10:35AM  Volatile Week For Tech ETFs But Sector's 'Tremendous Run Will Continue'
10:35AM  S&P 500 ETFs Rise Led By Tech Sector With Trump Gamble In Spotlight
09:32AM  U.S. stocks open slightly higher, but on track for worst week since November at MarketWatch
08:48AM  What's working: Health care stocks
08:05AM  Rep. Brooks: GOP health care billl one of the 'worst' I'v...
07:49AM  Restoring balance in health coverage: CEO
07:44AM  Rep. Johnson: AHCA restores trust in health care delivery
07:37AM  Did Februarys Jobs Report Improve Confidence in the US Economy?
07:33AM  House will likely 'eke' out health care deal: Pro
07:20AM  ACA's biggest problem is using balance sheet of private h...
07:06AM  Single-payer health care system stymies innovation: CEO
06:34AM  Expect a lot of changes in GOP's AHCA: Expert
06:08AM  Best bets in health care stocks: Pro
Mar-23-17 06:18PM  Healthcare delay What you need to know in markets on Friday
04:25PM  Dow edges down for 6th straight decline after health-care vote delay at MarketWatch
04:10PM  Health-care stocks end lower following the delay of a key vote on a new health bill at MarketWatch
12:44PM  Healthcare Stocks Await TrumpCare Vote at Barrons.com
11:44AM  Today's charts: Community Health Systems, HCA Holdings, Tenet Healthcare gain ahead of health care vote
10:06AM  Health Care Vote Looms With Market Focused On Possible Tax Policy Implications
Mar-22-17 03:41PM  A Response To Jim Cramers Why Im Against ETFs
11:25AM  Health ETF Wobbles As Vote On Bill To Replace ObamaCare Nears; Gold Gains
07:48AM  Rep. Yarmuth: We'd love to work with GOP on drug costs
07:42AM  Rep. Yarmuth: GOP health bill 'ideological exercise' to s...
07:15AM  Health care stocks under GOP plan
Mar-21-17 12:49PM  4 Health Care Charts Signaling Buys: Pfizer, Amgen Included
Mar-20-17 03:55PM  What Will A Protracted Government Battle Over Healthcare Mean For Tax Reform, Infrastructure?
10:31AM  Post Rate Hike, Here's How to Trade the 11 S&P Sector ETFs
Mar-19-17 10:04PM  How Much You'd Spend On Healthcare Under New GOP Plan, By Income
01:21PM  Businesses Will Be Impacted By Trumpcare
Mar-18-17 11:17AM  Week Ahead: All Eyes on Technology's Momentum
Mar-17-17 04:22PM  Dow, S&P 500 Decline as Health Care Losses Counter Gains
02:41PM  Broad Gains Overshadow Health Care Losses to Boost Wall Street
02:06PM  How Low Volatility Is Helping the 2017 Market Surge
10:46AM  Stocks Creep Lower as Health Care Selloff Extends Into Day 2
10:16AM  An Interesting Long/Short Sector ETF Trade Idea
08:51AM  Your first trade for Friday, March 17 at CNBC
07:39AM  Why Did the Healthcare Sector Fall on March 16?
Mar-16-17 05:58PM  Final Trade: BAC, COH & more
01:09PM  A Cost-Efficient Avenue to Health Care Exposure at Investopedia
12:53PM  Biogen Weighs On Biotech ETFs; Time to Bail? at Barrons.com
08:09AM  That Was Fast: Healthcare ETF Races To New Highs
Mar-15-17 02:13PM  Pfizers Cash Flow Stamina versus Mercks Ambitious R&D
10:37AM  David Tepper on Allergan: Does It Look Cheap?
Mar-13-17 10:45AM  Real Estate, Energy Warn as Health Care, Technology Lead
08:21AM  We want something better than Obamacare: Rep. McCarthy
08:12AM  Health care reform will come in 3 phases: Rep. McCarthy
08:06AM  Tax reform starts with health care reform: Rep. Kevin MCa...
08:05AM  GOP pushes Obamacare overhaul: Rep. Kevin McCarthy
07:41AM  GOP's health plan has 'fatal flaw': Tom Coburn
06:51AM  Street eyes battle for health care control
Mar-10-17 02:17PM  Trump administration expected to name VC partner Gottlieb to head FDA at MarketWatch
11:46AM  What the House Republican bill gets wrong about the health insurance market at MarketWatch
Mar-09-17 04:05PM  These Health Care ETFs Could Be in Play with the GOP's ACA Repeal
02:56PM  Rising Rates Not Biggest Driver For Financials
02:18PM  Brookings Institution expects CBO estimate of at least 15 million more uninsured under Republican health care bill at MarketWatch
07:03AM  Mark Cubans Obamacare fix: Only cover all chronic or life-threatening conditions at MarketWatch
04:09AM  Trumps Obamacare Lite presents opportunities and perils for investors at MarketWatch
Mar-08-17 01:00PM  An ETF Vulnerable to an Obamacare Repeal at Investopedia
08:50AM  Your first trade for Wednesday, March 8 at CNBC
07:07AM  Demand offers big opportunity in health care stocks: Pro
05:31AM  Heres whats led stocks from bull market to bear market and back again at MarketWatch
Mar-07-17 05:58PM  Final Trade: VIAB, SPY & more
05:07PM  3 large-cap buys to play strength in health care: Ross
05:00PM  5 ways to trade health care after AHC unveil
04:21PM  What Wall Street Thinks Of The New Healthcare Reform Bill
12:11PM  Drug innovators will continue to do well: Isaly
11:32AM  Healthcare Stocks Fall, But Still Appear Strong at Investopedia
10:47AM  Are You In The Best Health Care ETF? GOP Moves To Replace ObamaCare
07:04AM  Market Recon: We Witness the Opening Kickoff of the Political Football on Healthcare
Mar-06-17 04:01PM  The 2 Sides Of The Affordable Care Act Debate, Explained
01:40PM  Real Estate, Energy Sectors Flash Warnings for Stocks
Mar-02-17 11:07AM  No Ides Of March For These Sector ETFs...Maybe
07:37AM  Dupixent May Help Diversify Regenerons Revenues in 2017
Mar-01-17 05:32PM  Did Biotech Get a Presidential Pardon? at Barrons.com
12:38PM  Trump continues to focus on drug pricing
Feb-28-17 08:24PM  S&P 500 books best monthly gain in a year at MarketWatch
12:54PM  February ETF Asset Report: EM Gains, U.S. Loses
07:37AM  Understanding Alexions Profit Margin Trend in 2017
07:36AM  Elanco, Eli Lilly & Co.s Animal Health Segment
05:44AM  Heres how analysts say you should trade Trumps speech to Congress at MarketWatch
Feb-27-17 04:09PM  Dow, S&P 500 Brush Aside Earlier Jitters to Close at Fresh Records
03:36PM  What Are Analysts Recommendations for Merck in 2017?
03:35PM  Bristol-Myers Squibb Expects Modest Revenue Growth in 2017
07:37AM  Why Vertex Expects Its Profit Margin to Rise in 2017
07:13AM  Valeant sub Salix hired 250 employees to bolster its GI commitment at MarketWatch
Feb-24-17 07:36AM  Merck & Co.s Animal Health Segment
Feb-23-17 05:04PM  5 Things Republicans Want To Change About Obamacare But Might Not Be Able To
07:52AM  Solid Uptake of This Drug Could Drive Gileads 2017 Product Sales
Feb-22-17 01:51PM  Goldman Says Buy Health-Care, Retail Volatility Before Trump Address at The Wall Street Journal
Feb-21-17 03:19PM  This Medical Device ETF Is Healthier Than its Sector at Investopedia
01:35PM  Goldman Sachs and the Proposed Repeal of Obamacare
Feb-17-17 03:58PM  Pisani: Trump rally still in tact
10:36AM  Amgen Is Managing the Life Cycle of Its Mature Nephrology Drugs in 2017
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
CAG Conagra Brands, Inc. daily Stock Chart
CAG [NYSE]
Conagra Brands, Inc.
IndexS&P 500 P/E39.87 EPS (ttm)1.02 Insider Own0.10% Shs Outstand435.21M Perf Week-2.29%
Market Cap17.61B Forward P/E21.57 EPS next Y1.88 Insider Trans-0.75% Shs Float434.28M Perf Month-0.07%
Income448.00M PEG3.08 EPS next Q0.44 Inst Own79.40% Short Float1.05% Perf Quarter7.05%
Sales10.51B P/S1.68 EPS this Y-36.90% Inst Trans0.69% Short Ratio1.48 Perf Half Y20.54%
Book/sh10.16 P/B3.98 EPS next Y10.61% ROA4.90% Target Price41.69 Perf Year20.55%
Cash/sh3.38 P/C11.98 EPS next 5Y12.95% ROE16.10% 52W Range32.74 - 41.68 Perf YTD2.85%
Dividend0.80 P/FCF27.82 EPS past 5Y-10.30% ROI7.30% 52W High-2.90% Beta0.35
Dividend %1.98% Quick Ratio1.30 Sales past 5Y-1.20% Gross Margin28.40% 52W Low23.60% ATR0.56
Employees20900 Current Ratio1.90 Sales Q/Q-11.50% Oper. Margin9.20% RSI (14)47.75 Volatility1.79% 1.25%
OptionableYes Debt/Eq0.78 EPS Q/Q45.40% Profit Margin6.00% Rel Volume1.13 Prev Close40.35
ShortableYes LT Debt/Eq0.72 EarningsMar 23 BMO Payout69.90% Avg Volume3.09M Price40.47
Recom2.20 SMA20-1.24% SMA501.31% SMA2008.62% Volume3,503,170 Change0.30%
Mar-21-17Downgrade Bernstein Mkt Perform → Underperform
Feb-15-17Initiated Deutsche Bank Buy $46
Jan-11-17Upgrade Citigroup Neutral → Buy
Dec-23-16Reiterated Credit Suisse Neutral $35 → $40
Nov-14-16Initiated UBS Neutral $36
Nov-09-16Resumed JP Morgan Overweight $55
Oct-19-16Reiterated Stifel Hold $46 → $52
Oct-14-16Upgrade RBC Capital Mkts Sector Perform → Outperform $50 → $54
Jul-01-16Reiterated RBC Capital Mkts Sector Perform $48 → $50
Apr-08-16Reiterated Jefferies Buy $50 → $52
Apr-04-16Reiterated RBC Capital Mkts Sector Perform $46 → $48
Feb-25-16Resumed Goldman Neutral $48
Feb-12-16Upgrade BofA/Merrill Neutral → Buy
Dec-16-15Initiated Jefferies Buy
Sep-25-15Reiterated Deutsche Bank Hold $38 → $43
Jul-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $37 → $50
Jul-01-15Upgrade BofA/Merrill Underperform → Neutral
Jun-22-15Upgrade JP Morgan Neutral → Overweight
Jun-19-15Reiterated Deutsche Bank Hold $36 → $38
Jun-19-15Reiterated Bernstein Mkt Perform $37 → $44
Mar-25-17 02:44AM  [$$] Consumer Staples Could Be in for a Fall at Barrons.com
Mar-24-17 10:54AM  ConAgra Posts Mixed Q3 Earnings at Investopedia
08:35AM  Delta Apparel, Inc. (DLA) Shows Strength: Stock Up 6.3%
Mar-23-17 09:36PM  Edited Transcript of CAG earnings conference call or presentation 23-Mar-17 1:30pm GMT
09:53AM  ConAgra (CAG) Beats on Q3 Earnings, Updates FY17 Guidance
09:20AM  Conagra (CAG) Beats on Q3 Earnings, Lags Revenues
08:23AM  ConAgra beats 3Q profit forecasts
08:03AM  Conagra's profit beats on reduced discounting, higher prices
07:47AM  CONAGRA BRANDS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
07:44AM  Conagra shares fall after sales miss at MarketWatch
07:42AM  ConAgra Stock Dips Premarket on Mixed Results
07:30AM  Conagra Brands Reports Continued Margin Expansion And EPS Growth In Third Quarter PR Newswire
07:19AM  Market Recon: Focus on Capital Preservation Ahead of Health Care Vote
07:07AM  Q3 2017 Conagra Brands Inc Earnings Release - 07:30 am ET
Mar-22-17 09:30AM  Zacks.com featured highlights: Conagra Brands, Broadcom, Deere, Electronic Arts and CBRE Group
08:30AM  Vince Holding Corp (VNCE) Catches Eye: Stock Jumps 10.7%
Mar-21-17 10:25AM  Thanasi Buyout Continues ConAgra's Transformation at Investopedia
10:19AM  General Mills (GIS) Beats on Q3 Earnings, Sales Fall Shy
09:55AM  GameStop's (GME) May Disappoint in Q4 Earnings: Here's Why
09:26AM  Bernstein Downgrades Food Names on Industry Weakness
09:08AM  Conagra Brand (CAG) to Post Q3 Earnings: Is a Beat in Store?
07:58AM  5 Top ROE Stocks to Make the Most of a Placid Market
07:23AM  ConAgra downgraded by Bernstein
Mar-20-17 09:30AM  FedEx, Nike, Accenture, ConAgra and Micron Technologyare part of Zacks Earnings Preview
Mar-17-17 06:03PM  This is why Washington wrangling could become a bigger deal in the week ahead at CNBC
12:15PM  Boulder meat snack company acquired by Conagra Brands at bizjournals.com
09:32AM  Finish Line (FINL) to Post Q4 Earnings: What's in the Cards?
09:06AM  Conagra (CAG) to Revamp Portfolio on Thanasi & BIGS Buyout
Mar-16-17 05:00PM  Conagra Brands Enters Into Definitive Agreement To Acquire Thanasi Foods, Maker Of Duke's® Meat Snacks And BIGS® Seeds PR Newswire
07:28AM  Conagra Brands Announces Details Of Fiscal 2017 Third Quarter Earnings Release, Webcast And Conference Call PR Newswire
Mar-15-17 10:27AM  Here's Why Dollar General's (DG) Q4 Earnings May Disappoint
Mar-10-17 02:54PM  TreeHouse (THS) Prospects Look Promising: Should You Hold?
Mar-09-17 06:13PM  Why J & J Snack Foods Is a Better Stock Than ConAgra Now
11:21AM  Billionaire Barry Rosensteins Top Q4 Moves: Alphabet (GOOG), Bristol-Myers (BMY), More at Insider Monkey
09:31AM  Tyson Farm Bird Flu Found Less Menacing than Chinese Variant
Mar-07-17 08:16AM  Molson Coors (TAP) Prices Senior Notes to Repay Term Loan
Mar-06-17 09:30AM  Zacks.com featured highlights: Conagra Brands, General Motors, Texas Instruments, Electronic Arts and Celanese
07:35AM  Can Adidas (ADDYY) Spring a Surprise this Earnings Season?
Mar-03-17 04:22PM  Should You Retain J.M. Smucker (SJM) After Q3 Earnings Miss?
08:26AM  Mondelez: Cost-Saving Plan Bodes Well, Macro Woes Remain
07:14AM  5 Top ROE Stocks to Buy as Markets Hit Record High
Mar-02-17 06:21PM  SUPERVALU (SVU) Prospects Bleak: Time to Sell the Stock?
06:20PM  Reynolds' Shares Advance on Decent Earnings: Time to Buy?
06:10PM  Can United Natural (UNFI) Spring a Surprise in Q2 Earnings?
Mar-01-17 04:55PM  Pinnacle Foods (PF) Prospects Look Bright: Time to Buy?
01:57PM  Conagra Brands Is a 'Healthy Choice' for Upside
Feb-28-17 09:54AM  Tyson Foods (TSN) Prospects Look Attractive: Time to Buy?
Feb-27-17 01:00PM  Walmart Takes a Hatchet to Its Grocery Prices as It Declares War on Aldi and Kroger
09:41AM  Buffett boosts Apple stake, Tesla hit with sell rating, Walmart could ignite price wars
Feb-22-17 01:29PM  ConAgra CEO hopes border tax can bring opportunities, but it is 'too early to tell yet' at CNBC
Feb-20-17 09:48AM  Unilever Rejects Undervalued Merger Bid from Kraft Heinz
Feb-17-17 05:22PM  CONAGRA BRANDS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
09:39AM  Campbell Soup (CPB) Tops Q2 Earnings, Keeps FY17 Guidance
Feb-16-17 09:30AM  Zacks.com featured highlights: Conagra Brands, General Motors, Texas Instruments, Monsanto and Celanese
Feb-15-17 05:31PM  Kraft Heinz profit tops estimates as costs fall
01:54PM  Conagra Could See 15% Upside In The Next 12 Months
07:52AM  Trump's Tax Cut Plan on the Anvil: 5 ROE Stocks to Buy
Feb-14-17 02:44PM  Molson Coors (TAP) Q4 Earnings, Sales Lags Estimates
10:59AM  Top Ranked Momentum Stocks to Buy for February 14th
Feb-13-17 10:30AM  Hain Celestials: Still Not A Buy at Barrons.com
Feb-10-17 12:56PM  TreeHouse Foods (THS) Q4 Earnings & Sales Beat Estimates
Feb-09-17 07:49PM  Cramer Remix: The real winner of the Pepsi-Coke challenge at CNBC
07:10PM  After surging 12%, TreeHouse could be your next play on organic & natural food at CNBC
06:57PM  After surging 12% TreeHouse could be your next play on or...
10:23AM  TreeHouse Shares Soar on Better Than Expected 2016 Results
08:37AM  Pilgrim's Pride (PPC) Misses on Q4 Earnings and Revenues
Feb-06-17 10:43AM  Sysco (SYY) Q2 Earnings Top on Higher Margins, Sales Meet
Feb-02-17 11:02AM  Philip Morris (PM) Q4 Earnings Miss, Sales Beat Estimates
Feb-01-17 10:22AM  Tyson Foods (TSN) to Report Q1 Earnings: What Lies in Store?
Jan-29-17 12:02PM  ConAgra CEO on Trump, defining "healthy" and Reddi-wip
Jan-26-17 08:03AM  Orville Redenbacher's Fans Stock up for Football's Biggest Game PR Newswire
Jan-25-17 10:38AM  McCormick (MKC) Q4 Earnings Meet, Sales Miss Estimates
Jan-24-17 07:18AM  Altria Shares March Higher on Sherman Buyout, Bright View
Jan-23-17 05:18PM  CONAGRA BRANDS INC. Files SEC form 8-K, Other Events
11:04AM  Why Is ConAgra Foods (CAG) Down 1.5% Since the Last Earnings Report?
Jan-20-17 09:33AM  Helen of Troy (HELE) Poised to Grow in 2017: Time to Buy?
Jan-19-17 12:31PM  ETFs with exposure to Conagra Brands, Inc. : January 19, 2017
Jan-17-17 04:51PM  Pinnacle Foods (PF) Stock Could Be a Great Pick: Here's Why
03:27PM  ConAgra Brands CEO on Turnaround: Long Way to Go
03:27PM  ConAgra Brands CEO on Turnaround: Long Way to Go at Bloomberg
03:04PM  ConAgra CEO: Innovation is as important in food business as it is in anybody's business at CNBC
03:03PM  Conagra CEO Connolly: 'The Name of the Game Now is Driving Growth, Innovation'
09:02AM  Reynolds (RAI) Downgraded to Sell on Macro Headwinds
08:19AM  Conagra Brands, Inc. :CAG-US: Earnings Analysis: Q2, 2017 By the Numbers : January 17, 2017
Jan-16-17 10:37AM  Citigroup Upgrades Conagra Brands to a Buy
09:07AM  Raymond James Upgrades Visteon Corporation to Outperform
07:37AM  Who Were the Outliers in the Consumer Space on January 12?
Jan-11-17 09:48AM  Top Ranked Income Stocks to Buy for January 11th
09:30AM  The Zacks Analyst Blog Highlights: JPMorgan, Texas Instruments, Starbucks, ConAgra and NVIDIA
08:43AM  Conagra's (CAG) Growth Initiatives Look Good: Time to Buy?
08:33AM  Brown-Forman's Growth Efforts on Track Amid Currency Woes
Jan-10-17 01:45PM  Top Research Reports for Starbucks, JPMorgan & Texas Instruments
09:28AM  [$$] Lamb Weston Tops Views in First Quarterly Report at The Wall Street Journal
Jan-09-17 09:01AM  Reddi-wip Introduces New Recipe Business Wire
Jan-07-17 01:04PM  CONAGRA BRANDS INC. Financials
Jan-05-17 09:07AM  Whats the Latest News on Hormel Foods?
Jan-04-17 09:12AM  CONAGRA BRANDS INC. Files SEC form 10-Q, Quarterly Report
08:15AM  Post Earnings Coverage as ConAgra Adjusted EPS Soared 25.6% Accesswire
08:00AM  Microwave Popcorn a Delicious Whole Grain Option for Those Seeking Sensible Snacks PR Newswire
Jan-03-17 03:15PM  Conagra or Ingredion: Which Stock Is More Appealing?
Conagra Brands, Inc., together with its subsidiaries, operates as a food company in North America. It operates through five segments: Grocery & Snacks, Refrigerated & Frozen, International, Foodservice, and Commercial. The Grocery & Snacks segment primarily provides branded, shelf-stable food products in various retail channels in the United States. The Refrigerated & Frozen segment offers branded, temperature controlled food products in various retail channels in the United States. The International segment primarily provides branded food products, in various temperature states, in retail and foodservice channels outside of the United States. The Foodservice segment offers branded and customized food products, such as meals, entrees, prepared potatoes, sauces, and various custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The Commercial segment offers commercially branded and private label food and ingredients primarily to commercial, restaurant, foodservice, food manufacturing, and industrial customers. The company markets its products primarily under the Healthy Choice, Hunt's, Slim Jim, Reddi-wip, Alexia, Blake's, Frontera, Bertolli, P.F. Chang's, and Marie Callender's brands. The company was formerly known as ConAgra Foods, Inc. and changed its name to Conagra Brands, Inc. in November 2016. Conagra Brands, Inc. was founded in 1919 and is headquartered in Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GREGOR JOIE ADirectorJan 05Sale39.013,300128,73750,820Jan 09 05:17 PM
Biegger DavidEVP,Chief Supply Chain OfficerNov 17Option Exercise0.006,52806,528Nov 21 05:46 PM
Serrao DarrenEVP, Chief Growth OfficerSep 01Option Exercise0.003,23503,235Sep 06 06:04 PM
Wise Robert GSVP, Corporate ControllerJul 15Option Exercise36.8915,708579,46834,326Jul 19 09:35 PM
Wise Robert GSVP, Corporate ControllerJul 15Sale47.9015,708752,36618,618Jul 19 09:35 PM
Wise Robert GSVP, Corporate ControllerJul 14Option Exercise30.8917,245532,69835,863Jul 18 04:21 PM
Wise Robert GSVP, Corporate ControllerJul 14Sale48.1917,245830,97418,618Jul 18 04:21 PM
JURGENSEN WILLIAM GDirectorJul 08Option Exercise24.549,000220,860119,356Jul 08 04:51 PM
JURGENSEN WILLIAM GDirectorJul 08Sale47.884,636221,972114,720Jul 08 04:51 PM
BUTLER STEPHEN GDirectorJul 07Option Exercise24.549,000220,86089,850Jul 08 04:50 PM
GOLDSTONE STEVEN FDirectorJul 07Option Exercise24.5481,1681,991,863191,922Jul 08 04:51 PM
GOLDSTONE STEVEN FDirectorJul 07Sale48.0441,4701,992,132150,452Jul 08 04:51 PM
BUTLER STEPHEN GDirectorJul 07Sale48.104,607221,59785,243Jul 08 04:50 PM
Johri RajiveDirectorJul 06Option Exercise21.4715,000322,05051,259Jul 08 04:56 PM
Johri RajiveDirectorJul 06Sale47.5315,000712,87736,259Jul 08 04:56 PM
Wise Robert GSVP, Corporate ControllerJul 05Option Exercise36.8936,6541,352,16655,272Jul 07 08:47 PM
Gehring JohnEVP and CFOJul 05Option Exercise34.58159,0575,499,729218,766Jul 07 08:56 PM
Gehring JohnEVP and CFOJul 05Sale48.14159,0577,657,06859,709Jul 07 08:56 PM
Wise Robert GSVP, Corporate ControllerJul 05Sale48.1636,6541,765,27118,618Jul 07 08:47 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 12Option Exercise30.8912,992401,323118,541Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 12Sale46.3512,992602,179105,549Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 11Option Exercise24.7410,000247,400115,549Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 11Sale46.2510,000462,500105,549Apr 13 04:51 PM
McGough Thomas MPresident, Consumer FoodsApr 07Option Exercise26.1560,0001,569,000116,341Apr 11 04:50 PM
McGough Thomas MPresident, Consumer FoodsApr 07Sale46.0060,0002,760,00056,341Apr 11 04:50 PM
GILD Gilead Sciences, Inc. daily Stock Chart
GILD [NASD]
Gilead Sciences, Inc.
IndexS&P 500 P/E6.79 EPS (ttm)9.94 Insider Own0.40% Shs Outstand1.31B Perf Week-2.24%
Market Cap88.24B Forward P/E8.96 EPS next Y7.54 Insider Trans-11.21% Shs Float1.30B Perf Month-1.93%
Income13.50B PEG- EPS next Q2.26 Inst Own77.90% Short Float1.04% Perf Quarter-8.02%
Sales30.39B P/S2.90 EPS this Y-16.50% Inst Trans0.32% Short Ratio1.27 Perf Half Y-16.01%
Book/sh14.36 P/B4.70 EPS next Y-8.59% ROA25.60% Target Price79.06 Perf Year-24.15%
Cash/sh9.16 P/C7.37 EPS next 5Y-4.81% ROE83.50% 52W Range64.88 - 100.48 Perf YTD-5.00%
Dividend2.08 P/FCF6.55 EPS past 5Y41.20% ROI31.00% 52W High-32.81% Beta1.14
Dividend %3.08% Quick Ratio2.00 Sales past 5Y29.40% Gross Margin86.00% 52W Low4.05% ATR1.03
Employees9000 Current Ratio2.20 Sales Q/Q-13.90% Oper. Margin58.00% RSI (14)40.24 Volatility1.21% 1.39%
OptionableYes Debt/Eq1.39 EPS Q/Q-26.40% Profit Margin44.40% Rel Volume0.57 Prev Close67.49
ShortableYes LT Debt/Eq1.39 EarningsFeb 07 AMC Payout18.30% Avg Volume10.67M Price67.51
Recom2.30 SMA20-1.81% SMA50-2.99% SMA200-10.20% Volume6,037,090 Change0.03%
Mar-09-17Resumed UBS Neutral $118 → $72
Feb-08-17Downgrade Citigroup Buy → Neutral
Nov-14-16Initiated Stifel Buy $100
Nov-08-16Initiated Mizuho Buy $88
Nov-02-16Reiterated RBC Capital Mkts Outperform $95 → $90
Oct-25-16Reiterated Jefferies Buy $93 → $95
Oct-03-16Reiterated RBC Capital Mkts Outperform $105 → $95
Sep-27-16Downgrade Leerink Partners Outperform → Mkt Perform $112 → $94
Sep-12-16Initiated Berenberg Buy $112
Sep-06-16Upgrade Jefferies Hold → Buy
Jul-29-16Downgrade Argus Buy → Hold
Jul-26-16Reiterated RBC Capital Mkts Outperform $120 → $105
Jul-26-16Downgrade Needham Buy → Hold
Jun-01-16Initiated Gabelli & Co Buy $109
Apr-29-16Reiterated UBS Buy $130 → $118
Apr-29-16Downgrade Maxim Group Buy → Hold
Mar-16-16Reiterated Leerink Partners Outperform $130 → $127
Feb-25-16Initiated Citigroup Buy $110
Feb-12-16Reiterated Maxim Group Buy $137 → $115
Feb-03-16Reiterated RBC Capital Mkts Outperform $130 → $120
Mar-24-17 08:04AM  The Best-Case Scenario for Gilead Sciences, Inc. at Motley Fool
Mar-23-17 10:57AM  Biotechs Back in the Doghouse After Failed Rally at Investopedia
Mar-22-17 04:23PM  My 3 Worst-Performing Stocks -- and Why I Still Own Them at Motley Fool
09:30AM  Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen
Mar-21-17 04:22PM  Mylan Receives Tentative Approval from FDA for HIV Therapy
04:00PM  British Columbia lists EPCLUSA on public drug plan to treat all six genotypes of chronic hepatitis C infection CNW Group
08:52AM  Ionis Pharmaceuticals Valuation Compared to Its Peers
Mar-20-17 04:22PM  3 Stocks That Are Ridiculously Cheap Right Now at Motley Fool
01:08PM  Gilead Sciences: Wait, Its Pipeline Isn't Completely Barren? at Barrons.com
12:25PM  EPCLUSA, to treat all six genotypes of chronic hepatitis C infection, added to the Liste des médicaments de la RAMQ CNW Group
10:06AM  Why Biotech Stock Gilead (GILD) Could Be a Value Trap
09:50AM  Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now
Mar-17-17 11:03AM  3 Drug Stocks With Some of the Highest Profit Margins at Motley Fool
Mar-16-17 03:40PM  3 Numbers That Make Gilead Sciences, Inc. Look Cheaper Than It Really Is at Motley Fool
08:02AM  Dividend Stocks Hedge Funds Are Betting On at Insider Monkey
07:08AM  [$$] Celgene Shows Savvy as Gilead Keeps Backsliding at Barrons.com
Mar-15-17 05:40PM  Forget Gilead, Buy These Small-Cap Biotech Stocks Instead
09:54AM  Wait, Gilead Might Actually Hit Its 1st Quarter Numbers?!?! at Barrons.com
08:03AM  3 Reasons Why Gilead Sciences Will Buy Incyte -- and 1 Reason Why It Won't at Motley Fool
Mar-14-17 10:55AM  Gilead Looking To Buy Incyte? It Makes Sense
07:36AM  Johnson & Johnsons Pharmaceuticals Segment
05:18AM  This titanic stock market has that sinking feeling at MarketWatch
Mar-13-17 06:20PM  After-hours buzz: VRX, INCY, COUP & more at CNBC
05:27PM  Executive Chairman Slashes Stake in Gilead Sciences
04:48PM  Incyte Spikes To Record High On Rumors Gilead Could Acquire It
03:42PM  Is Incyte For Sale? at Investopedia
02:08PM  Biotech stocks are turning bullishhere's how to profit
10:22AM  Gilead Sciences: Is an Incyte Deal 'Reasonable'? at Barrons.com
09:49AM  3 Underdog Stocks We're Watching Closely at Motley Fool
06:00AM  Barclays Lists 5 Steps to Boost GILD Stock
Mar-12-17 06:42AM  3 Healthcare Stocks That Are Looking Cheap at Motley Fool
Mar-11-17 11:41AM  Which Biotech Is the Best Dividend Stock? at Motley Fool
12:35AM  [$$] Resisting the Allure of Gilead at Barrons.com
Mar-10-17 05:01PM  The Hot Stock: Incyte Soars 8.1% on Gilead Takeover Speculation at Barrons.com
04:30PM  Incyte Pops on Continued Gilead Takeout Speculation
02:33PM  Adam Feuerstein Weighs In On Novo-GBT Rumors, Undue Sarepta Volatility, Unprofitable Business Of Curing Disease
02:13PM  Dear Gilead: Buy Something Anything Analyst Pleads
02:13PM  Analyst Pleads With Gilead To Buy And It May Have Worked
01:12PM  AbbVie Stock Upgraded: What You Need to Know at Motley Fool
12:37PM  Gilead Sciences: Just Any Deal Won't Do at Barrons.com
11:46AM  How Gilead Is Paying The Price For Actually Curing A Disease
11:34AM  Is Gilead Sciences Worthy of Your Portfolio? at Insider Monkey
11:32AM  Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump
10:30AM  Major Biotechs See a Retreat in Short Interest
07:51AM  How Incyte Stock Became a Bull Market Star for Biotech Investors
Mar-09-17 04:55PM  Will Merck, Glaxo Undercut Gilead's Next 'Mount Everest' Drug?
04:31PM  Momo Dives Despite Price Target Hike; UBS Initiates Biotechs; Mercury Is A Buy
04:21PM  Will Gilead Sciences Net a $270 Million Windfall? at Motley Fool
01:40PM  Drugs, travel, jewelry and social media in the blitz
01:25PM  What Does Gilead Need? Stable HCV Scripts and "a String of Pearls" at Barrons.com
12:38PM  3 Biotech Stocks to Buy Nowand 1 to Dump ASAP at Barrons.com
11:02AM  Gilead: "Stuck Between A Rock And A Hard Place?" at Barrons.com
10:44AM  I Was Wrong About Gilead Sciences at Motley Fool
Mar-08-17 04:22PM  This Pharma Firm Is Beating The Pack In Getting Drugs To Market
07:25AM  Are Hedge Funds Turning Bearish on Healthcare Stocks? at Insider Monkey
Mar-07-17 03:50PM  The healthcare industry is starting to turn on itself as pressure over drug prices heats up
03:04PM  3 Biotech Stocks You Don't Have to Babysit at Motley Fool
12:38PM  Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan
08:04AM  Here's Why the Best Is Yet to Come for Gilead Sciences, Inc. at Motley Fool
Mar-06-17 02:35PM  Jeff Auxier Invests in Gilead, Wells Fargo, Apple
01:29PM  Bristol-Myers Squibb: Don't Get Your Hopes Up at Barrons.com
01:10PM  RBC Hints At Potential M&A For Kite Pharma
Mar-05-17 03:03PM  How Are Drug Prices Determined? at Motley Fool
Mar-03-17 04:13PM  Gilead Executive Says Pharmacy Benefit Managers Keep Prices High
02:49PM  Is Gilead's Guidance Conservative? at Barrons.com
01:04PM  GILEAD SCIENCES INC Financials
11:11AM  2 Reasons Behind Sarepta Therapeutics Inc.'s 6.9% February Jump at Motley Fool
Mar-02-17 09:30AM  Zacks Industry Outlook Highlights: Sanofi, AstraZeneca, Novo Nordisk, Gilead Sciences and Valeant Pharmaceuticals International
07:37AM  How Gileads Other Products Fared in 2016
Mar-01-17 06:43PM  Pricing to Remain Pharma Headline Risk in 2017
06:08PM  Jerome Dodson Adds to 9 Positions in 4th Quarter
11:55AM  Gilead Sciences: M&A to the Rescue? at Barrons.com
10:37AM  How Gileads Liver Disease Drugs Portfolio Performed
09:07AM  How Gileads HIV Drugs Portfolio Fared in 2016
08:06AM  Carl Icahn Takes Aim at Bristol-Myers Squibb at Motley Fool
07:38AM  How Gileads Revenue Trended in 2016
07:24AM  Biotech Stock Roundup: Kite Soars on CAR-T Data, EXEL in Immuno-Oncology Deals
Feb-28-17 05:54PM  Why Gileads Valuation Is Low Compared to Peers
05:00PM  Gilead Sciences to Present at the Barclays Global Healthcare Conference on Tuesday, March 14 Business Wire
10:15AM  Short Sellers Hike Their Bets in Major Biotechs
09:06AM  Pfizers Major Product Developments in 4Q16
09:06AM  Eli Lilly & Co.s Recent Developments
08:01AM  3 Top Healthcare Stocks to Buy Now at Motley Fool
07:37AM  Understanding Alexions Profit Margin Trend in 2017
Feb-27-17 04:26PM  GILEAD SCIENCES INC Files SEC form 10-K, Annual Report
01:21PM  Better Buy: Biogen Inc. vs. Gilead Sciences Inc. at Motley Fool
11:22AM  3 Stocks That Are Ridiculously Cheap Right Now at Motley Fool
10:00AM  SBPH: 2016 Results Sustaining Continued HBV/STING Development
08:05AM  Merck Restates 2016 Earnings, Takes $2.9B Charge at Investopedia
07:57AM  These 3 Big Pharma Stocks Are Ridiculously Cheap at Motley Fool
07:37AM  Why Vertex Expects Its Profit Margin to Rise in 2017
06:00AM  Drugmakers Eye $35B Market Amid Obesity Crisis at Investopedia
Feb-24-17 04:14PM  Gilead, AbbVie Could Perk Up On Merck's Hep C Downfall: Leerink
01:21PM  NASH Is Todd Hagopian's Top Biotech Sub-Sector For 2017 at Forbes
11:11AM  Ten Stocks That Still Look Cheap at Barrons.com
10:57AM  3 Incredibly Cheap Biotech Stocks at Motley Fool
09:20AM  7 Ultra-Cheap Value Stocks to Buy Now at Kiplinger
07:37AM  Gilead Sciences Expects a Fall in Its HCV Product Sales in 2017
Feb-23-17 05:06PM  AbbVie Stronger Bet Than Gilead, Amgen At Least Until 2020: Leerink
02:25PM  Gilead Sciences, Inc. (GILD) EPCLUSA Access To Be Provided In Ontario For Treatment Of Hepatitis C at Insider Monkey
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in Europe, North America, Asia, South America, Africa, Australia, India, and the Middle East. The company's products include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Vemlidy, Epclusa, Harvoni, Sovaldi, Viread, and Hepsera products for treating liver diseases. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis C virus and hepatitis B virus; hematology/oncology; cardiovascular; and inflammation/respiratory diseases. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company, Janssen R&D Ireland, Japan Tobacco Inc., and Galapagos NV. The company was founded in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARTIN JOHN CExecutive ChairmanMar 01Option Exercise21.5873,3331,582,1593,199,969Mar 03 06:29 PM
MOORE NICHOLAS GDirectorMar 01Option Exercise0.00173012,055Mar 03 06:03 PM
MARTIN JOHN CExecutive ChairmanMar 01Sale70.3873,3335,161,2063,126,636Mar 03 06:29 PM
WILSON GAYLE EDirectorFeb 23Option Exercise20.7133,350690,512140,836Feb 27 06:29 PM
MILLIGAN JOHN FPresident and CEOFeb 23Option Exercise21.58100,0002,157,5001,165,924Feb 27 06:13 PM
WILSON GAYLE EDirectorFeb 23Sale69.3020,3651,411,374120,471Feb 27 06:29 PM
YOUNG KEVINChief Operating OfficerFeb 10Option Exercise0.0090802,883Feb 14 12:53 PM
MARTIN JOHN CExecutive ChairmanFeb 01Option Exercise21.5873,3331,582,1593,204,429Feb 03 05:25 PM
YOUNG KEVINChief Operating OfficerFeb 01Option Exercise0.0062002,190Feb 03 05:32 PM
MARTIN JOHN CExecutive ChairmanFeb 01Sale72.5773,3335,322,0693,131,096Feb 03 05:25 PM
MARTIN JOHN CExecutive ChairmanJan 03Option Exercise21.5873,3371,582,2463,204,433Jan 05 03:39 PM
MARTIN JOHN CExecutive ChairmanJan 03Sale73.5973,3375,396,9713,131,096Jan 05 03:39 PM
MARTIN JOHN CExecutive ChairmanDec 01Option Exercise16.40100,0001,639,5003,231,096Dec 05 12:54 PM
WILSON GAYLE EDirectorDec 01Option Exercise0.002,1470107,486Dec 05 07:59 PM
MARTIN JOHN CExecutive ChairmanDec 01Sale73.33100,0007,332,8703,131,096Dec 05 12:54 PM
MADIGAN JOHN WDirectorNov 18Option Exercise20.71105,0002,174,025121,761Nov 22 02:45 PM
MADIGAN JOHN WDirectorNov 18Sale74.86105,0007,860,05916,761Nov 22 02:45 PM
Alton Gregg HEVP Comm&Acs ALA, Corp&Med AffNov 09Sale79.0010,000790,000122,964Nov 14 01:03 PM
MARTIN JOHN CExecutive ChairmanNov 01Option Exercise16.40100,0001,639,5003,231,096Nov 03 06:10 PM
MARTIN JOHN CExecutive ChairmanNov 01Sale73.76100,0007,376,0463,131,096Nov 03 06:10 PM
MARTIN JOHN CExecutive ChairmanOct 03Option Exercise16.40100,0001,639,5003,231,096Oct 05 12:52 PM
MARTIN JOHN CExecutive ChairmanOct 03Sale77.63100,0007,762,9613,131,096Oct 05 12:52 PM
Alton Gregg HEVP Comm&Acs ALA, Corp&Med AffSep 22Sale81.845,000409,220132,964Sep 26 04:54 PM
MILLIGAN JOHN FPresident and CEOSep 06Option Exercise20.7470,0001,451,8001,128,963Sep 08 01:35 PM
MILLIGAN JOHN FPresident and CEOSep 06Sale77.7470,0005,442,0801,058,963Sep 08 01:35 PM
MARTIN JOHN CExecutive ChairmanSep 01Option Exercise16.40100,0001,639,5003,231,096Sep 06 02:40 PM
MARTIN JOHN CExecutive ChairmanSep 01Sale77.48100,0007,748,3633,131,096Sep 06 02:40 PM
Lofton Kevin EDirectorAug 24Sale81.973,500286,8990Aug 25 05:05 PM
Carter Paul RutherfordEVP Commercial OpsAug 01Option Exercise39.132,00078,25564,305Aug 03 04:48 PM
MARTIN JOHN CExecutive ChairmanAug 01Option Exercise16.40100,0001,639,5004,119,727Aug 03 04:51 PM
MILLIGAN JOHN FPresident and CEOAug 01Option Exercise20.7470,0001,451,8001,128,963Aug 03 04:53 PM
MILLIGAN JOHN FPresident and CEOAug 01Sale70.9470,0004,965,5901,058,963Aug 03 04:53 PM
MARTIN JOHN CExecutive ChairmanAug 01Sale80.50100,0008,049,7854,019,727Aug 03 04:51 PM
Carter Paul RutherfordEVP Commercial OpsAug 01Sale79.812,000159,62062,305Aug 03 04:48 PM
Carter Paul RutherfordEVP Commercial OpsJul 31Option Exercise0.002,500063,622Aug 02 04:43 PM
MILLIGAN JOHN FPresident and CEOJul 05Option Exercise16.40112,0001,836,2401,170,963Jul 07 02:50 PM
MILLIGAN JOHN FPresident and CEOJul 05Sale84.33112,0009,444,9211,058,963Jul 07 02:50 PM
Carter Paul RutherfordEVP Commercial OpsJul 01Option Exercise24.912,00049,81063,122Jul 06 01:26 PM
MARTIN JOHN CExecutive ChairmanJul 01Option Exercise16.40100,0001,639,5004,119,727Jul 06 01:28 PM
MARTIN JOHN CExecutive ChairmanJul 01Sale84.73100,0008,472,5234,019,727Jul 06 01:28 PM
Carter Paul RutherfordEVP Commercial OpsJul 01Sale83.122,000166,25061,122Jul 06 01:26 PM
MILLIGAN JOHN FPresident and CEOJun 06Option Exercise16.40112,0001,836,2401,170,963Jun 08 06:59 PM
MILLIGAN JOHN FPresident and CEOJun 06Sale86.94112,0009,736,7791,058,963Jun 08 06:59 PM
Carter Paul RutherfordEVP Commercial OpsJun 01Option Exercise24.912,00049,81063,122Jun 03 04:46 PM
MARTIN JOHN CExecutive ChairmanJun 01Option Exercise16.40100,0001,639,5004,119,727Jun 03 04:51 PM
MARTIN JOHN CExecutive ChairmanJun 01Sale86.72100,0008,671,9504,019,727Jun 03 04:51 PM
Carter Paul RutherfordEVP Commercial OpsJun 01Sale87.022,000174,04061,122Jun 03 04:46 PM
Carter Paul RutherfordEVP Commercial OpsMay 31Option Exercise33.8857,0921,934,021118,214Jun 02 04:35 PM
Carter Paul RutherfordEVP Commercial OpsMay 31Sale86.8557,0924,958,60061,122Jun 02 04:35 PM
MARTIN JOHN CExecutive ChairmanMay 02Option Exercise16.40100,0001,639,5004,119,727May 04 02:44 PM
MILLIGAN JOHN FPresident and CEOMay 02Option Exercise16.40112,0001,836,2401,170,963May 04 02:49 PM
Carter Paul RutherfordEVP Commercial OpsMay 02Option Exercise39.132,00078,25563,122May 04 04:23 PM
Carter Paul RutherfordEVP Commercial OpsMay 02Sale88.722,000177,44861,122May 04 04:23 PM
MILLIGAN JOHN FPresident and CEOMay 02Sale87.71112,0009,823,9541,058,963May 04 02:49 PM
MARTIN JOHN CExecutive ChairmanMay 02Sale87.82100,0008,781,6944,019,727May 04 02:44 PM
Alton Gregg HEVP, Corp & Med AffairsApr 19Option Exercise26.9935,874968,239177,964Apr 21 01:28 PM
Alton Gregg HEVP, Corp & Med AffairsApr 19Sale100.0140,0004,000,574137,964Apr 21 01:28 PM
MILLIGAN JOHN FPresident and CEOApr 04Option Exercise16.40112,0001,836,2401,170,963Apr 05 07:30 PM
MILLIGAN JOHN FPresident and CEOApr 04Sale94.59112,00010,593,9041,058,963Apr 05 07:30 PM
MARTIN JOHN CExecutive ChairmanApr 01Option Exercise16.40100,0001,639,5004,119,727Apr 05 07:49 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Option Exercise24.912,00049,81063,122Apr 05 06:36 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Sale91.342,000182,68061,122Apr 05 06:36 PM
MARTIN JOHN CExecutive ChairmanApr 01Sale93.24100,0009,323,5074,019,727Apr 05 07:49 PM
Alton Gregg HEVP, Corp & Med AffairsApr 01Sale91.235,000456,158142,090Apr 05 07:45 PM
V Visa Inc. daily Stock Chart
V [NYSE]
Visa Inc.
IndexDJIA S&P500 P/E42.19 EPS (ttm)2.11 Insider Own0.10% Shs Outstand2.32B Perf Week-1.16%
Market Cap206.99B Forward P/E23.09 EPS next Y3.86 Insider Trans-28.56% Shs Float1.85B Perf Month1.15%
Income5.99B PEG2.62 EPS next Q0.79 Inst Own95.10% Short Float2.31% Perf Quarter14.36%
Sales15.98B P/S12.95 EPS this Y-19.60% Inst Trans0.30% Short Ratio5.25 Perf Half Y7.42%
Book/sh11.15 P/B8.00 EPS next Y16.53% ROA9.80% Target Price97.90 Perf Year21.21%
Cash/sh4.10 P/C21.74 EPS next 5Y16.10% ROE20.80% 52W Range72.83 - 92.05 Perf YTD14.53%
Dividend0.66 P/FCF50.17 EPS past 5Y9.90% ROI13.60% 52W High-3.11% Beta0.95
Dividend %0.74% Quick Ratio1.40 Sales past 5Y10.40% Gross Margin- 52W Low22.46% ATR0.98
Employees11300 Current Ratio1.40 Sales Q/Q25.10% Oper. Margin53.70% RSI (14)57.19 Volatility1.71% 1.03%
OptionableYes Debt/Eq0.63 EPS Q/Q7.40% Profit Margin37.50% Rel Volume0.93 Prev Close88.86
ShortableYes LT Debt/Eq0.54 EarningsFeb 02 AMC Payout23.00% Avg Volume8.15M Price89.19
Recom1.80 SMA200.16% SMA503.49% SMA2009.75% Volume7,597,000 Change0.37%
Feb-15-17Initiated Loop Capital Buy $98
Feb-03-17Reiterated Stifel Buy $93 → $105
Jan-20-17Upgrade Wedbush Neutral → Outperform $77 → $96
Dec-15-16Upgrade BofA/Merrill Neutral → Buy
Dec-05-16Upgrade Guggenheim Neutral → Buy
Oct-25-16Reiterated Stifel Buy $94 → $93
Oct-25-16Reiterated RBC Capital Mkts Outperform $87 → $89
Oct-25-16Downgrade Guggenheim Buy → Neutral
Jul-22-16Reiterated Stifel Buy $86 → $91
Jun-06-16Resumed JP Morgan Overweight $88
Apr-20-16Reiterated Sun Trust Rbsn Humphrey Buy $85 → $100
Apr-15-16Initiated Compass Point Neutral $80
Feb-11-16Downgrade BofA/Merrill Buy → Neutral
Dec-17-15Initiated Sterne Agee CRT Buy
Dec-16-15Initiated UBS Buy $90
Nov-03-15Reiterated RBC Capital Mkts Outperform $82 → $91
Oct-22-15Resumed Wells Fargo Outperform
Oct-19-15Reiterated Oppenheimer Outperform $81 → $85
Aug-20-15Reiterated Barclays Overweight $80 → $85
Jul-24-15Reiterated Topeka Capital Markets Hold $66 → $70
Mar-24-17 07:08PM  Why the Payments Industry Needs Partnerships to Thrive at Motley Fool
11:48AM  Square's chip credit card readers just got 14% faster
07:36AM  PayPal or Amazon Payments: Which Is the Steeper Hill to Climb?
Mar-23-17 01:08PM  Large and In Charge in the Payments Industry at Motley Fool
09:06AM  Heres How PayPal Could Make a Competition Crisis an Opportunity
Mar-22-17 10:29AM  Where Social Media and the Payments Industry Meet at Motley Fool
Mar-21-17 08:04PM  Better Buy: Square, Inc. vs. Visa at Motley Fool
07:22PM  Why PayPal's Future Is Cooperation, Not Competition at Motley Fool
06:15PM  Key Lessons Learned from the Hottest Options Trades
03:33PM  If You're in Your 30s, Consider Buying These Stocks at Motley Fool
07:35AM  Visa Expected to See Lower Leverage and Repurchases in 2017
Mar-20-17 10:41AM  Visa tests contactless payment sunglasses
10:36AM  Visa Is Investing in Innovative Solutions and Emerging Markets
07:36AM  These Factors Could Drive Visa Services and Data Processing Growth
Mar-17-17 04:48PM  This Top Big-Cap Financial Stock Is A Buy As Goldman, Morgan Stanley Test 50-Day
01:05PM  Visas Transactions to Benefit from US and Asia Spending
11:35AM  What Will Drive Visas Payment Volumes?
10:12AM  MasterCard (MA) Continues to Invest in Growth Amid Headwinds
09:59AM  Visa Expected to See Strong Performance in March 2017
06:00AM  Visa, MasterCard and the Cashless Society at Investopedia
Mar-16-17 06:46PM  Visa vs. MasterCard: Which Stock Is More Lucrative?
Mar-15-17 01:41PM  The Federal Funds Rate And How It Impacts You
Mar-14-17 04:14PM  Coho Capital Gushes Over 5 Stocks With Unassailable Moats, Significant Earnings Growth at Insider Monkey
04:09PM  Update: Visa Inc. to Present at the Barclays Emerging Payments Forum Business Wire
06:00AM  What Strength in Visa and Square Shares Say About Payments at Investopedia
Mar-13-17 05:31PM  Visa is floating the idea of paying for stuff with your sunglasses at CNBC
02:30PM  Here's What Makes Visa's CFO So Bullish About 2017
02:00PM  Visa & StubHub Achieve Perfect Harmony in Austin Business Wire
11:48AM  New highs for the CNBC IQ 100
Mar-10-17 10:08AM  The Payments World: PayPal Vs. Apple Pay Vs. Visa Checkout Vs. Masterpass Vs. Amazon Payments Vs. Facebook Payments
07:00AM  Winning the War for Wallets at Morningstar
Mar-08-17 04:40PM  [$$] Market Talk: Daily Analysis Roundup at The Wall Street Journal
04:05PM  Visa Inc. to Host Investor Day Business Wire
03:04PM  Samsung Beats Apple to the Mobile Payment Punch in India
01:47PM  Visa, Inc. :V-US: Earnings Analysis: Q1, 2017 By the Numbers : March 8, 2017
10:58AM  Mobile Payments Can Boost Growth And Profitability at Forbes
09:16AM  A Look Into Billionaire Steve Cohens Major Q4 Additions at Insider Monkey
09:00AM  Visa and Girl Starter Team Up to Empower Female-Led Startups Business Wire
05:08AM  How to take your kids to Disney World for free (almost) at MarketWatch
Mar-07-17 03:35PM  Inside Costcos Fiscal 2Q17 Earnings
12:41PM  New highs in the CNBC IQ 100 Index
Mar-06-17 03:37PM  Morgan Stanley Still Likes Visa Better Than PayPal at Barrons.com
01:44PM  Invest Like Warren Buffett with These 5 Excellent Stocks
10:14AM  10 Most Ethical Companies In The US at Insider Monkey
05:55AM  Visa (V) Up 7.9% Since Earnings Report: Can It Continue?
Mar-04-17 02:07PM  3 Companies That Could Win Big With Trump Tax Reform at Motley Fool
Mar-03-17 05:30PM  Here's Why Costco (COST) Stock Tumbled 4% Today
05:16PM  A Major Proponent of H-1B Visa Reform Loses Patience With Trump
Mar-01-17 09:30AM  The Zacks Analyst Blog Highlights: AT&T, Visa, Biogen, Tesla and PG&E
Feb-27-17 01:17PM  UBS: Costco is going to raise membership fees next quarter
10:44AM  Barclays Names Costco Catalysts
09:00AM  Visa Supports Credit Unions With New Talent Initiatives Business Wire
06:00AM  Here's Why Visa, Merck and Home Depot Are Primed to Lead the S&P Higher
12:00AM  Visa to Launch First Everywhere Initiative in Europe Business Wire
12:00AM  mVisa to Expand to 10 Countries Business Wire
Feb-24-17 11:27AM  [$$] Mastercard, Visa to See 'Minimal Risk' From New European Rules at Barrons.com
08:48AM  Trump Visa Crackdown Threatens Biotech
03:28AM  Money Laundering Rules Hit Wealthy U.K. Visa Applications: Chart
Feb-23-17 10:25AM  Banks and retailers reignite the debit card fee war. It's hard to know who to root for
08:42AM  Costco's Big Credit Card Bet Has Paid Off at Motley Fool
Feb-22-17 07:34PM  You'd be a fool to bet against the market now: Cramer
07:01PM  Cramer: Is the Market Playing 'The Price Is Wrong'?
06:31PM  Cramer spells out why you would be a fool to bet against ...
06:13PM  Cramer spells out why you would be a fool to bet against the market now at CNBC
04:04PM  4 Stocks at 52-Week Highs That Are Still Worth Buying Today at Motley Fool
09:30AM  The Zacks Analyst Blog Highlights: Goldman Sachs Group, JPMorgan Chase, American Express and Visa
Feb-21-17 04:05PM  Visa Inc. to Participate in Upcoming Investor Conferences Business Wire
12:58PM  Finding Edge in Visa (V) Options
09:58AM  4 Blue Chip Stocks to Ride the Stellar Dow Jones Rally
Feb-20-17 11:45AM  Better Buy: Visa Inc. vs. MasterCard at Motley Fool
Feb-19-17 07:54AM  5 Stocks With Promising, Amazon-like Growth Potential at Motley Fool
Feb-16-17 05:06PM  Consumer Financial Protection Bureau wants to help boost your credit score
01:40PM  IBM, Visa Partnering on an IoT Payment Platform at Investopedia
09:00AM  IBM and Visa Turn Automobiles, Appliances and All Other Connected Devices into Potential Points of Sale with Watson Internet of Things PR Newswire
09:00AM  IBM and Visa Turn Automobiles, Appliances and All Other Connected Devices into Potential Points of Sale with Watson Internet of Things CNW Group
08:15AM  Post Earnings Coverage as Visa Reported Robust Results: Revenue Surged 25%, Adjusted EPS Soared 23% Accesswire
12:00AM  Trump, Congress and the Push for Work Visa Reform: QuickTake Q&A at Bloomberg
Feb-15-17 11:37AM  Billionaire Ken Griffin Piles Up Shares of Visa Inc. (V), Sherwin-Williams Co (SHW), Charter Communications, Inc. (CHTR) And More at Insider Monkey
09:14AM  Coverage initiated on Visa by Loop Capital
Feb-14-17 07:58PM  Visa: Cramer's Top Takeaways
07:30PM  Cramer Remix: Your roadmap to the rules of a new stock market at CNBC
07:26PM  Cramer Remix: Your roadmap to the rules of a new stock ma...
06:54PM  Visa's CEO talks about the global push into digital comme...
06:35PM  A Tectonic Shift of a Rally: Cramer's 'Mad Money' Recap (Tuesday 2/14/17)
04:13PM  Visa Checkout Is Growing Fast -- but Is That Enough? at Motley Fool
01:54PM  Canada's SecureKey wins U.S. grant for digital identity network
Feb-13-17 04:24PM  Apple, Nike, Visa Among Dow's Top 5 Gainers So Far This Year
09:30AM  The Zacks Analyst Blog Highlights: Coca-Cola, Walt Disney, Visa, Boeing and Merck
Feb-11-17 11:22AM  Smooth Integration with Visa Europe Fuels Another Strong Quarter for Visa Inc at Motley Fool
Feb-10-17 05:41PM  Dow 30 Stock Roundup: Coca-Cola, Disney, Visa Beat on Earnings
Feb-08-17 04:33PM  Nasdaq ekes out gains for new record, Dow hobbled by financials at MarketWatch
01:41PM  Rep. Darrell Issa Seeks to Revamp H-1B Visa Program at Bloomberg
01:04PM  VISA INC. Financials
10:36AM  Visa Gets Strong Buy from Analysts on Performance
09:30AM  The Zacks Analyst Blog Highlights: Apple, Visa and AbbVie
09:06AM  Visa Commanding Premium Valuations on Expected Growth in 2017
07:36AM  Visas Investments for Future Growth: Asian Markets
Feb-07-17 04:05PM  Visa Inc. to Participate in Upcoming Investor Conferences Business Wire
01:03PM  Biotech Executives Alarmed Over Trump Visa Crackdown at Bloomberg
10:59AM  Fidelity (FIS) Q4 Earnings Meet Estimates, Revenue Up Y/Y
Visa Inc. operates as a payments technology company worldwide. The company facilitates commerce through the transfer of value and information among consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It operates VisaNet, a processing network that enables authorization, clearing, and settlement of payment transactions; and offers fraud protection for account holders and assured payment for merchants. The company also offers gateway services for merchants to accept, process, and reconcile payments; manage fraud; and safeguard payment security online, as well as processing services for participating issuers of visa debit, prepaid, and ATM payment products. In addition, it provides digital products, including Visa Checkout that offers consumers an expedited and secure payment experience for online transactions; and Visa Direct, a push payment product platform, which facilitates payer-initiated transactions that are sent directly to the Visa account of the recipient, as well as Visa token service that replaces the card account numbers from the transaction with a token. Further the company offers corporate (travel) and purchasing card products, as well as value-added services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brands. The company has a strategic partnership agreement with Oman Arab Bank to convert the bank's current electron cards to chip-and-PIN debit cards. Visa Inc. was incorporated in 2007 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HOFFMEISTER JAMES HSVP, GBL CORP CONTRL & CAOFeb 07Option Exercise23.166,680154,7098,611Feb 08 04:35 PM
HOFFMEISTER JAMES HSVP, GBL CORP CONTRL & CAOFeb 07Sale86.006,680574,4801,931Feb 08 04:35 PM
HOFFMEISTER JAMES HSVP, GBL CORP CONTRL & CAOFeb 06Option Exercise23.161,95645,3016,390Feb 08 04:35 PM
Sheedy William M.EVP CORP STRAT, M&A, GRFeb 06Option Exercise14.12125,3721,769,939365,769Feb 07 06:16 PM
Sheedy William M.EVP CORP STRAT, M&A, GRFeb 06Sale85.74125,37210,749,521240,397Feb 07 06:16 PM
HOFFMEISTER JAMES HSVP, GBL CORP CONTRL & CAOFeb 06Sale85.874,459382,9101,931Feb 08 04:35 PM
MCINERNEY RYANPRESIDENTNov 08Sale82.9218,5001,534,09038,321Nov 09 07:06 PM
SCHARF CHARLES WCHIEF EXECUTIVE OFFICEROct 28Option Exercise40.05772,91230,956,4591,006,756Oct 28 08:00 PM
SCHARF CHARLES WCHIEF EXECUTIVE OFFICEROct 28Sale82.65772,91263,883,109233,844Oct 28 08:00 PM
PPG PPG Industries, Inc. daily Stock Chart
PPG [NYSE]
PPG Industries, Inc.
IndexS&P 500 P/E49.21 EPS (ttm)2.11 Insider Own0.10% Shs Outstand256.66M Perf Week-0.67%
Market Cap26.64B Forward P/E15.09 EPS next Y6.88 Insider Trans0.00% Shs Float255.56M Perf Month1.16%
Income564.00M PEG5.83 EPS next Q1.32 Inst Own73.50% Short Float1.46% Perf Quarter8.69%
Sales14.75B P/S1.81 EPS this Y-56.90% Inst Trans-3.20% Short Ratio2.02 Perf Half Y1.46%
Book/sh18.46 P/B5.62 EPS next Y10.37% ROA5.20% Target Price111.10 Perf Year-3.23%
Cash/sh7.26 P/C14.30 EPS next 5Y8.45% ROE17.20% 52W Range88.91 - 115.17 Perf YTD9.96%
Dividend1.60 P/FCF52.34 EPS past 5Y-4.50% ROI6.50% 52W High-9.88% Beta1.39
Dividend %1.54% Quick Ratio1.20 Sales past 5Y2.30% Gross Margin45.30% 52W Low16.74% ATR2.04
Employees47000 Current Ratio1.50 Sales Q/Q-1.50% Oper. Margin5.70% RSI (14)52.68 Volatility1.98% 2.17%
OptionableYes Debt/Eq0.92 EPS Q/Q-73.10% Profit Margin5.90% Rel Volume0.69 Prev Close104.62
ShortableYes LT Debt/Eq0.78 EarningsApr 20 BMO Payout47.10% Avg Volume1.85M Price103.79
Recom2.20 SMA200.51% SMA502.50% SMA2003.50% Volume1,284,338 Change-0.79%
Mar-15-17Upgrade Atlantic Equities Neutral → Overweight
Mar-09-17Downgrade Wells Fargo Outperform → Market Perform
Jan-17-17Downgrade Susquehanna Positive → Neutral
Jan-09-17Downgrade Citigroup Buy → Neutral
Dec-13-16Downgrade RBC Capital Mkts Outperform → Sector Perform $105 → $101
Oct-25-16Downgrade Argus Buy → Hold
Oct-21-16Downgrade Goldman Buy → Neutral
Oct-11-16Reiterated RBC Capital Mkts Outperform $125 → $106
Oct-11-16Downgrade Deutsche Bank Buy → Hold $122 → $100
Jul-26-16Upgrade Seaport Global Securities Accumulate → Buy $125 → $130
Jun-23-16Upgrade Longbow Neutral → Buy
Mar-22-16Resumed Credit Suisse Outperform
Jan-22-16Reiterated Deutsche Bank Buy $110 → $105
Jan-05-16Initiated Seaport Global Securities Accumulate $115
Nov-25-15Reiterated RBC Capital Mkts Outperform $115 → $129
Oct-16-15Upgrade UBS Neutral → Buy $122
Oct-16-15Reiterated Barclays Equal Weight $120 → $115
Oct-12-15Upgrade Goldman Neutral → Buy $107 → $113
Sep-14-15Reiterated RBC Capital Mkts Outperform $126 → $115
Sep-08-15Reiterated RBC Capital Mkts Outperform $145 → $126
Mar-24-17 12:41PM  PPG CEO leaves Netherlands, remains ready to meet with Akzo boards
12:27PM  Akzo Nobel Refuses to Meet With PPG Executive Team
12:17PM  Why PPG's Bid to Take Over Akzo May Fail: QuickTake Q&A
11:59AM  PPG chief snubbed by Akzo during Netherlands visit
11:56AM  [$$] PPG bid forces Akzo Nobel's Ton Büchner to play defence at Financial Times
09:06AM  American Dealmakers, It Pays to Be Polite
08:11AM  PPG Announces Automotive and Industrial Coatings Price Increases in Europe Business Wire
07:27AM  PPG Keeps Up Pressure on Akko Nobel in $26.3 Billion Takeover Showdown
06:20AM  PPG to make case for Akzo acquisition to Dutch govt officials
Mar-23-17 03:20PM  [$$] Pressure mounts on Akzo to engage in takeover talks with PPG at Financial Times
02:11PM  PPG Begins COLORFUL COMMUNITIES Project at Alabama Constitution Village in Huntsville Business Wire
01:50PM  [$$] Akzo Nobel Urged to Engage With PPG at The Wall Street Journal
12:25PM  Akzo Nobel finds unwanted suitor PPG on its doorstep Reuters
12:05PM  What Analysts Recommend for PPG Industries
10:37AM  Was PPG Industries Revised Offer to AkzoNobel Fair?
10:11AM  Akzo Nobel Shares Jump After Key Investor Urges PPG Meeting
10:10AM  Company News for March 23, 2017
09:45AM  PPG Comex, Concessionaires Earn GUINNESS WORLD RECORDS Title for Largest Paint-Can Mosaic Business Wire
09:19AM  Elliott Advisors criticises Akzo for refusal to meet with PPG Reuters
09:02AM  Why AkzoNobel Rejected PPGs 2nd Takeover Bid
08:15AM  Blog Coverage PPG Revises its Proposal to Acquire Akzo Nobel Accesswire
07:39AM  PPG Confirms Rejection of Revised Offer by AkzoNobel
06:39AM  PPG's McGarry in Amsterdam to promote "compelling" Akzo offer Reuters
06:06AM  PPG INDUSTRIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:48AM  PPG Chief Open to Hostile Bid Option After Akzo Spurns Offer
12:51AM  [$$] Deal or No Deal, Akzo Shareholders Can Win From PPG Bid at The Wall Street Journal
12:50AM  [$$] Elliott Threatens to Force Akzo Nobel to Engage With PPG at The Wall Street Journal
12:35AM  PRESS DIGEST- New York Times business news - March 23 Reuters
Mar-22-17 07:01PM  Cramer: Investing in Europe May Not Be Such a Bad Idea
05:32PM  [$$] Elliott Threatens to Force Akzo Nobel to Engage With PPG at The Wall Street Journal
04:29PM  Sears, Nike and US Bancorp stumble while FedEx, Duluth rise
03:50PM  Different approaches could be stumbling block to PPG-Akzo Nobel deal at bizjournals.com
03:29PM  Shareholders urge Akzo to negotiate with suitor PPG Reuters
03:12PM  Akzo Nobel CEO: won't meet with PPG to talk about bid
01:19PM  [$$] Akzo Nobel shareholders urge talks with rival PPG at Financial Times
12:41PM  [$$] Akzo Nobel/PPG: get his drift at Financial Times
11:35AM  [$$] Deal or No Deal, Akzo Shareholders Can Win From PPG Bid at The Wall Street Journal
10:11AM  PPG says Akzo offer good for staff, shareholders
09:58AM  Top Akzo investor Columbia Threadneedle says wants firm to talk to PPG over deal Reuters
08:50AM  PPG Improves Akzo Nobel Offer to $26.3 Billion
08:38AM  Akzo Nobel rejects PPG's second takeover bid at bizjournals.com
08:29AM  Akzo No-No-Nobel
08:15AM  Post Earnings Coverage as Valspar's Quarterly Net Sales Increased 2.5% Accesswire
08:09AM  PPG Makes Revised Proposal to Combine with AkzoNobel Business Wire
05:02AM  European Stocks Slide as Global Markets Reverse 'Trump Rally' Optimism
04:23AM  [video]Akzo Nobel Shares Slump After It Spurns Second Takeover Approach From PPG
04:21AM  AkzoNobel drops 2.4% after rejecting second takeover bid from PPG at MarketWatch
04:16AM  Akzo Nobel rejects improved bid from U.S. rival PPG Reuters
03:53AM  Akzo Nobel Rejects PPG's Sweetened, $24 Billion Takeover Bid
Mar-21-17 07:01PM  Cramer: Europe Is Much More Bullish Than You Believe
03:21PM  Stocks Suffer Worst Losses of 2017 as Patience Over Trump Reform Promise Runs Thin
11:11AM  Stocks Extend Declines as Basic Materials, Financials Slump
09:19AM  GE, PepsiCo, PPG Industries, and More: Heres Why These Five Stocks Are Trending at Insider Monkey
08:24AM  Stock Futures Creep Higher as Crude Oil Rebounds
07:23AM  5 Things You Must Know Before the Market Opens Tuesday
04:47AM  Akzo Shares Hit Fresh Record High on PPG Bid Speculation
04:42AM  PPG prepares new bid for Akzo Nobel after first offer failed: Bloomberg at MarketWatch
04:42AM  PPG prepares new bid for Akzo Nobel after first offer failed: Bloomberg
Mar-20-17 06:03PM  PPG Said to Ready New Akzo Offer After Failed $22.4 Billion Bid
06:03PM  PPG Said to Prepare New Akzo Bid After $22.4 Billion Failed
12:54PM  Dutch provinces oppose Akzo Nobel takeover, fear job losses Reuters
10:09AM  PPG Industries (PPG) Launches Touchmix XI Color Tool
08:18AM  Axalta Plans to Increase Prices in China
Mar-17-17 11:17PM  [$$] Business Watch at The Wall Street Journal
05:57PM  [$$] Elliott Owns Stake in Akzo Nobel, Pushes for Talks With Suitor PPG at The Wall Street Journal
05:08PM  Elliott Management owns stake in Akzo Nobel, pushes for talks with suitor PPG at MarketWatch
Mar-16-17 07:07AM  Akzo CEO Said to Be Jolted Into Dealmaking to Fend Off PPG
Mar-15-17 10:23AM  PPG to Hike Automotive and Industrial Coatings Price in Asia
06:18AM  PPG Industries upgraded by Atlantic Equities
Mar-14-17 05:49PM  Unilever CEO urges UK to provide 'level playing field' after Kraft bid Reuters
02:08PM  Best Performing Stocks of All Time at Motley Fool
Mar-13-17 03:28PM  PPG Industries Proposes Combined Company with AkzoNobel
12:48PM  PPG Industries, Inc. -- Moody's affirms PPG's A3 ratings; outlook negative following rejected bid for Akzo Nobel at Moody's
09:24AM  PPG Industries Confirms Rejection of Offer by AkzoNobel
Mar-10-17 02:47PM  Europe Stocks Ride U.S. Jobs Data Higher: Banks, Deal Speculation Pace Gains
09:10AM  Company News for March 10, 2017
08:25AM  PPG to raise paint prices for car makers in Asia in April at MarketWatch
08:20AM  President Trump's first jobs report
08:15AM  Blog Coverage PPG Industries' Merger Proposal Rejected by AkzoNobel Accesswire
08:11AM  PPG Announces Automotive and Industrial Coatings Price Increases in Asia Business Wire
07:54AM  AkzoNobel Shares Hit Record High Amid Push for Group to Talk to PPG
07:39AM  Shareholder Henderson Global urges Akzo Nobel to talk to PPG Reuters
07:10AM  PPG's Akzo Price Is Not So Noble
12:07AM  [$$] PPG Makes $22 Billion Offer for Paint Rival Akzo Nobel, Is Rejected at The Wall Street Journal
Mar-09-17 06:25PM  [$$] PPG Makes $22 Billion Offer for Paint Rival Akzo Nobel, Is Rejected at The Wall Street Journal
05:34PM  Sears and Cincinnati Financial rise as PPG, Staples drop
05:09PM  Akzo Nobel rejects $22 billion PPG bid, looks to spin off chemicals Reuters
04:32PM  PPG INDUSTRIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11:48AM  Dutch See Red Over Foreign Bid for Paint Giant
11:12AM  PPG's Bid for Dutch Rival Rejected
10:34AM  Akzo Nobel rejects $22 bln PPG bid, looks to spin off chemicals Reuters
09:08AM  Stock Futures Little Changed as Oil Trades Below $50, ECB Holds Rates
08:40AM  AkzoNobel rejects $22B offer from PPG at bizjournals.com
07:57AM  Early movers: SPLS, SHLD, SIG, PPG, ELF & more at CNBC
07:13AM  Akzo's Chemicals Unit Said Valued at 10 Billion Euros in Sale
07:13AM  Akzo Chemicals Unit Said Valued at 10 Billion Euros in Sale
07:10AM  PPG Vows to Keep Pressure on AzkoNobel After Takeover Rejection
06:28AM  5 Things You Must Know Before the Market Opens Thursday
05:29AM  PPG Confirms Proposal for AkzoNobel Business Wire
04:07AM  European stocks pull back as oil shares fall, ECB statement on deck at MarketWatch
PPG Industries, Inc. manufactures and distributes coatings, specialty materials, and glass products. It operates in three segments: Performance Coatings, Industrial Coatings, and Glass. The Performance Coatings segment provides coatings products for automotive and commercial transport/fleet repair and refurbishing; light industrial and specialty coatings for signs; coatings, sealants, and transparencies for commercial, military, regional jet and general aviation aircraft, and transparent armor for specialty applications; protective and marine coatings and finishes; architectural coatings; and purchased sundries to painting contractors and consumers, as well as chemical management services. As of December 31, 2016, this segment operated company-owned stores approximately 920 stores in North America, 40 in Australia, and 75 in Central America. In addition, it sells coatings and related products through approximately 4,200 stores that are independently owned and operated by 700 concessionaires primarily in Mexico. The Industrial Coatings segment provides adhesives and sealants for the automotive industry; metal pretreatments and related chemicals for industrial and automotive applications; packaging coatings for the protection, performance, and decoration of metal cans, closures, plastic tubes, industrial packaging, and promotional and specialty packaging; precipitated silicas for tire, battery separator, and other markets; substrates used in radio frequency identification tags and labels, e-passports, drivers' licenses, and identification cards; organic light emitting diode materials for use in displays and lighting; optical lens materials and photochromic dyes for optical lenses and color-change products. The Glass segment produces fiber glass for use in commercial and residential construction, wind energy, energy infrastructure, transportation, and electronics industries. The company was founded in 1883 and is headquartered in Pittsburgh, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sklarsky Frank SExecutive VP & CFOFeb 28Option Exercise0.0010,000032,873Mar 02 10:36 AM
KNAVISH TIMOTHY MSr. VP, Automotive CoatingsAug 04Option Exercise63.749,300592,76219,506Aug 08 03:45 PM
KNAVISH TIMOTHY MSr. VP, Automotive CoatingsAug 04Sale104.089,300967,93110,206Aug 08 03:45 PM
SEKMAKAS VIKTORAS RExecutive Vice PresidentJul 26Option Exercise65.7630,4502,002,24069,044Jul 28 10:15 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentJul 26Sale106.6440,9504,367,01428,094Jul 28 10:15 AM
USHER THOMAS JDirectorApr 20Option Exercise0.001,09202,092Apr 22 03:30 PM
RICHENHAGEN MARTINDirectorApr 20Option Exercise0.001,092020,576Apr 22 03:25 PM
HOOPER MICHELE JDirectorApr 20Option Exercise0.001,092015,352Apr 22 03:16 PM
HON Honeywell International Inc. daily Stock Chart
HON [NYSE]
Honeywell International Inc.
IndexS&P 500 P/E20.09 EPS (ttm)6.21 Insider Own0.10% Shs Outstand760.72M Perf Week-1.88%
Market Cap94.92B Forward P/E16.29 EPS next Y7.66 Insider Trans-1.28% Shs Float759.73M Perf Month-0.04%
Income4.81B PEG2.88 EPS next Q1.62 Inst Own76.50% Short Float0.82% Perf Quarter7.03%
Sales39.30B P/S2.42 EPS this Y2.70% Inst Trans-0.75% Short Ratio2.12 Perf Half Y8.00%
Book/sh25.41 P/B4.91 EPS next Y8.84% ROA9.20% Target Price135.00 Perf Year14.53%
Cash/sh12.98 P/C9.61 EPS next 5Y6.98% ROE25.50% 52W Range104.07 - 127.52 Perf YTD8.28%
Dividend2.66 P/FCF38.15 EPS past 5Y21.50% ROI13.80% 52W High-2.16% Beta0.96
Dividend %2.13% Quick Ratio1.10 Sales past 5Y1.50% Gross Margin30.90% 52W Low19.89% ATR1.36
Employees131000 Current Ratio1.40 Sales Q/Q0.00% Oper. Margin16.40% RSI (14)50.02 Volatility1.08% 1.07%
OptionableYes Debt/Eq0.81 EPS Q/Q-12.40% Profit Margin12.20% Rel Volume0.76 Prev Close125.52
ShortableYes LT Debt/Eq0.63 EarningsApr 28 BMO Payout38.90% Avg Volume2.92M Price124.77
Recom1.80 SMA20-1.07% SMA502.14% SMA2007.96% Volume2,221,528 Change-0.60%
Oct-10-16Reiterated RBC Capital Mkts Outperform $138 → $133
Oct-06-16Initiated Robert W. Baird Outperform $135
Apr-25-16Reiterated Stifel Buy $127 → $129
Apr-25-16Reiterated RBC Capital Mkts Outperform $121 → $122
Apr-18-16Reiterated Barclays Overweight $107 → $122
Feb-01-16Reiterated Stifel Buy $106 → $113
Dec-17-15Reiterated Oppenheimer Outperform $117 → $120
Nov-16-15Reiterated Barclays Overweight $103 → $104
Oct-20-15Reiterated Argus Buy $115 → $118
Oct-19-15Reiterated RBC Capital Mkts Outperform $121 → $120
Jul-31-15Reiterated Barclays Overweight $120 → $118
Jul-29-15Reiterated Barclays Overweight $115 → $120
Jul-21-15Reiterated Argus Buy $115 → $118
Jul-20-15Reiterated Stifel Buy $116 → $120
Jul-20-15Reiterated RBC Capital Mkts Outperform $116 → $122
May-15-15Reiterated Cowen Outperform $112 → $116
Jan-27-15Reiterated Argus Buy $106 → $115
Jan-22-15Initiated UBS Neutral $105
Dec-16-14Reiterated Stifel Buy $109 → $112
Nov-25-14Reiterated RBC Capital Mkts Outperform $105 → $116
Mar-25-17 01:18AM  [$$] The World's Best CEOs: an Exclusive Barron's List at Barrons.com
Mar-24-17 02:15PM  Honeywell To Release First Quarter Financial Results And Hold Its Investor Conference Call On Friday, April 21 PR Newswire
Mar-22-17 04:23PM  Forget GE, Buy These 3 Diversified Conglomerates Instead
Mar-21-17 05:18PM  Honeywell Aerospace-made component now standard on Airbus aircraft at bizjournals.com
10:20AM  Four New Honeywell Safety Products Win Prestigious iF Design Awards for Innovation, User Design PR Newswire
09:57AM  Indian Refinery To Use Honeywell UOP Technology To Meet Rising Domestic Demand For Clean Fuels PR Newswire
09:00AM  Honeywell Auxiliary Power Units Now Standard On All Airbus A320s PR Newswire
Mar-20-17 09:57AM  Wantong Petrochemical Is First To Use Honeywell Hydrotreating Catalyst To Make Ultra-Low Sulfur Diesel PR Newswire
08:45AM  Honeywell's UOP Technology to Boost Diamond Green Output
04:00AM  Americas Whitest-Knuckle Airport Landings
Mar-17-17 09:57AM  Diamond Green Diesel To Expand Renewable Fuel Capacity Using Ecofining Technology From Honeywell UOP PR Newswire
09:15AM  Here's Why You Should Buy Honeywell, Sell General Electric
09:06AM  Where Is SWK Trading Compared to Peers?
Mar-16-17 05:35PM  SWKs Falling Dividend Story: A Closer Read
02:28PM  Is SWK Showing up the Competition in 2017?
01:48PM  3M Shareholders Ask and They Receive
11:36AM  Honeywell International, Inc. :HON-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017
08:02AM  Growing Pipeline Opportunities For CUI Global After Plunge at Forbes
Mar-15-17 12:16PM  Manufacturing Giants Back US Tax Reforms at Investopedia
Mar-13-17 05:05PM  What Does General Electrics Pension Plan Entail?
Mar-10-17 02:37PM  Why General Electric is Flying? at Barrons.com
02:36PM  Honeywell International Inc. (HON) Beats General Electric Company (GE) On The Following 4 Points at Insider Monkey
Mar-09-17 12:52PM  Honeywell Is Appealing Even After Recent Upside
12:13PM  Honeywell International's Latest Presentation: Here's What You Need to Know at Motley Fool
01:00AM  Honeywell's Smart Airport Technology To Maximize Safety And Efficiency At Turkey's Newest Airport PR Newswire
Mar-08-17 08:22AM  Honeywell (HON) Secures New Orders for Helicopter Engines
07:37AM  3M to Pay 1Q17 Dividend: Can It Sustain the Dividend Growth?
Mar-07-17 04:48PM  3M's an Income Buy That's Going Higher
09:00AM  Honeywell Helps U.S. Air Force Drive Efficiency Savings At Los Angeles Air Force Base PR Newswire
Mar-06-17 07:57PM  Why Have Helicopters Fallen Out Of Favor Worldwide?
04:03PM  HONEYWELL INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
01:00PM  Honeywell Engines Continue To Power Eagle 407HP Helicopters PR Newswire
12:39PM  Honeywell To Present At J.P. Morgan Aviation, Transportation And Industrials Conference PR Newswire
12:35PM  Honeywell Cuts Estimate on Global Helicopter Sales
11:00AM  Honeywell Receives Certification To Keep Helicopters Connected And Mission-Ready For Operators PR Newswire
10:13AM  Honeywell is new to managing Sandia, but not to Albuquerque at bizjournals.com
09:00AM  Honeywell Forecasts 3,900 To 4,400 Global Helicopter Deliveries Over Next Five Years PR Newswire
06:46AM  Defense Stock Roundup: Trump's Promise to Spend 'Big' Lifts Stocks; LMT, BA Win Deals; GD Ups Dividend
Mar-03-17 02:45PM  [$$] 3 Cheap Value Stocks With Dividends and Momentum at Barrons.com
Mar-02-17 12:56PM  Honeywell's Balancing Act
12:05PM  Instant Analysis: Honeywell International's Adamczyk Takes Center Stage